Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
  • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
  • C07D513/04—Ortho-condensed systems
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
  • A61K31/425—Thiazoles
  • A61K31/429—Thiazoles condensed with heterocyclic ring systems
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
  • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
  • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P11/00—Drugs for disorders of the respiratory system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P11/00—Drugs for disorders of the respiratory system
  • A61P11/06—Antiasthmatics
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P11/00—Drugs for disorders of the respiratory system
  • A61P11/08—Bronchodilators
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P13/00—Drugs for disorders of the urinary system
  • A61P13/12—Drugs for disorders of the urinary system of the kidneys
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P17/00—Drugs for dermatological disorders
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P17/00—Drugs for dermatological disorders
  • A61P17/04—Antipruritics
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P17/00—Drugs for dermatological disorders
  • A61P17/06—Antipsoriatics
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P17/00—Drugs for dermatological disorders
  • A61P17/10—Anti-acne agents
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P19/00—Drugs for skeletal disorders
  • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P27/00—Drugs for disorders of the senses
  • A61P27/02—Ophthalmic agents
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P27/00—Drugs for disorders of the senses
  • A61P27/16—Otologicals
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
  • A61P31/04—Antibacterial agents
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
  • A61P31/12—Antivirals
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P35/00—Antineoplastic agents
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P37/00—Drugs for immunological or allergic disorders
  • A61P37/08—Antiallergic agents
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
  • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
  • C07D277/84—Naphthothiazoles

Definitions

• Phosphatidylinositol 3-kinases are a subfamily of lipid kinases that catalyze the transfer of a phosphate moiety to the 3'-position of the inositol ring of phosphoinositides (Vanhaesebroeck and Waterfield, Exp. Cell Res. 1999 Nov 25; 253 (1): 239-54).
• PI3 kinases Due to their in vivo specificity for certain phosphoinositide substrates, the PI3 kinases can be divided into different classes.
• the members of the receptor-regulated class I are heterodimeric enzymes composed of a 1 10-120 kDa catalytic (p110) and a 50-101 kDa non-catalytic subunit (p50, p55, p85, p101).
• the most highly conserved region in all PI3 kinases is the C-terminal kinase domain. It has structural features that are also found in most known protein kinases. These include e.g. also highly conserved amino acids, which are responsible for the
• PI3 kinases constitutively associate with a 50-85 kDa adapter subunit, of which p85 is the prototype.
• the interaction occurs via the so-called p85 binding domain, which can be found on the catalytic subunits of the PI3 kinase ⁇ , ß and ⁇ .
• the three forms are grouped into Class IA because of this structural feature.
• the catalytic subunit of PI3 kinase ⁇ , p1 10 ⁇ instead associates with a 101 kDa regulatory protein called p101. It is - so far the only member - the class IB of the PI3 kinases.
• PI3K ⁇ is primarily activated by G ⁇ subunits released from heterotrimeric G proteins upon activation of heptahelical receptors. This different coupling to cell surface receptors in combination with a more or less restrictive expression inevitably results in very different tasks and functions of the 4 class I PI3 kinases in the intact organism (Wymann et al., Trends Pharmacol Sei. 2003 Jul; 7): 366-76).
• PI3-kinase activity was associated with the transforming activity of viral oncogenes, e.g. the middle T antigen of polyomavirus, Src
• Tyrosine kinases or activated growth factors (Workman, Biochem Soc Trans. 2004 Apr; 32 (Pt 2): 393-6).
• tumors e.g. Breast cancer, ovarian or even pancreatic carcinoma
• Akt / PKB an overactivity of Akt / PKB, which is activated directly by the lipid products of class I PI3 kinases and thus passes the signals into the cell.
• the PIK3CA gene coding for p110 ⁇ has a high frequency of mutations in several tumor types, such as colon, mammary or lung carcinomas, some of which have been characterized as activating mutations (Samuels et al , Science, 2004 Apr 23; 304 (5670): 554).
• mice The youngest member of the class IA PI3 kinases, the PI3K ⁇ , is more restrictively expressed than the PI3K ⁇ and ⁇ .
• PI3K ⁇ The youngest member of the class IA PI3 kinases, the PI3K ⁇ , is more restrictively expressed than the PI3K ⁇ and ⁇ .
• knock-in mice in which the catalytic subunit of PI3K ⁇ , p110 ⁇ , was replaced by an inactive mutant, it could be shown that this PI3K isoenzyme a specific role in the signal transmission of B and T lymphocytes after antigen-receptor stimulation (Okkenhaug et al., Science 2002 Aug; 297 (5583): 1031-4) .
• the PI3K ⁇ is activated almost exclusively by G-coupling heptahelical receptors. , Science formation can be observed when these were stimulated with IL-8, fMLP, LTB4 or C5a (Hirsch et al 2000 - so could in neutrophils in mice which express no PI3K ⁇ , no PI3, 4, 5-P. 3. Feb 11; 287 (5455): 1049-53). This demonstrates that, at least in this cell type, PI3K ⁇ is the only PI3 kinase isoform that couples to these heptahelical receptors.
• PI3K ⁇ plays a central role in the activation of various inflammatory cells, and therefore isoform-specific inhibitors represent an attractive option for anti-inflammatory therapy with comparatively low side effects (Ward and Finan, Curr Opin Pharmacol Aug; 3 (4): 426-34)
• PI3K ⁇ also appears to play a role in the cardiovascular system despite its low expression in cardiomyocytes.
• mice showed an increase in myocardial contractility, which can probably be explained by an overproduction of cAMP (Crackower et al., Cell 2002 Sep 20; 10 (6): 737-49).
• cAMP cAMP-activated kinase
• PI3K ⁇ is also involved in the development of cardiac hypertrophy.
• p110 ⁇ -deficient mice in a isoproterenol-induced heart failure model showed a markedly reduced hypertrophy and fibrosis in comparison with the wild-type animals (Oudit et al., Circulation 2003 Oct 28; 108 (17): 2147-52).
• the object of the present invention was to provide novel compounds which, because of their pharmaceutical activity, can be used as a PI3-kinase modulator for use in the therapeutic field for the treatment of inflammatory or allergic diseases.
• inflammatory and allergic respiratory diseases inflammatory diseases of the gastrointestinal tract, rheumatoid arthritis, inflammatory and allergic skin diseases, inflammatory eye diseases, diseases of the nasal mucosa, inflammatory or allergic disease states in which autoimmune reactions are involved or called kidney inflammation.
• PI3-kinase inhibitors for the treatment of inflammatory diseases are known in the literature.
• WO 03/072557 discloses 5-phenylthiazole derivatives
• WO 04/029055 shows fused azolpyrimidines
• WO 04/007491 azolidinone-vinyl-linked benzene derivatives
• the two documents WO 04/052373 and WO 04/056820 disclose benzoxazine benzoxazine-3-one derivatives.
• Y is carbon, nitrogen, sulfur; preferably carbon, nitrogen; Z is carbon, nitrogen, sulfur; preferably carbon, nitrogen; j 1, 2 or 3; k is 0 or 1;
• R a is H, COR 8 , NR 9 R 10 , NO 2 , OR 8 , SR 11 , SOR 11 , SO 2 R 11 , NHCO-C 1-6 -alkyl-NH 2 , or a radical selected from the group consisting of C 1-6 alkyl, C 2-6 alkenyl, C 3-8 cycloalkyl, C 3-8 cycloalkenyl, C 1-6 haloalkyl, aryl, C 7-11 aralkyl, spiro, Het, heteroaryl, and CH 2 -O-aryl which may be optionally substituted;
• R 8 is C 1-6 alkyl, C 3-6 cycloalkyl, NH 2 , hetaryl or aryl optionally substituted with one or more halo or C 1-4 alkyl;
• R 9 is H, COOR 12 , CONR 12 or C 1-6 alkyl optionally substituted with one or more COOH, N (C 1-6 alkyl) 2 or Het optionally substituted with one or more C 1-6 alkyl ; or R 9 is het optionally substituted with one or more C 1-4 alkyl;
• R 10 is H, d-beta-alkyl, CO-C 1-6 -alkyl or C 2-6 -alkynyl;
• R 11 is C 1-6 alkyl optionally substituted with one or more N (d -4 alkyl) 2 ;
• R 4 , R 5 H C 1-6 -alkyl, d- ⁇ -haloalkyl, C 1-6 -alkylene-OH, C 2-6 -alkenyl, C 7-11 -aralkyl, C 2-4 -alkenyl- Aryl, C 2-4 -alkynyl-aryl, C 1-4 -alkyl-H ⁇ -taryl, C 2-4 -alkenyl-hetaryl, C 2-4 -alkynyl-hetaryl, C 2-6 -alkynyl, optionally substituted with Si ( C 1-4 alkyl) 3 , or R 4 is a radical selected from the group consisting of aryl, het, hetaryl and optionally substituted by C 1-4 alkyl;
• R 4 and R 5 together form a five, six or seven membered ring consisting of carbon atoms and optionally a heteroatom selected from the group consisting of oxygen, nitrogen and sulfur; 1 c NHR 6 or a radical selected from the group consisting of
• B bond C 1-6 alkyl, C 2-6 alkenyl or C 2-6 alkynyl;
• R 6 is H or a radical selected from the group consisting of C 1-4 -alkyl, C 2-4 -alkenyl, C 2-4 -alkynyl, C 3-6 -cycloalkyl, C 3-6 -cycloalkenyl, het, aryl, hetaryl optionally substituted with one or more R 6 1 ;
• R 6 1 is halogen, CF 3 , OH, CN, OMe, SO 2 (C 1-4 alkyl);
• R 7 is H, C 1-4 alkyl, C 2-4 alkenyl, C 2-4 alkynyl, C 3-6 cycloalkyl, NR 7 1 R 72 , OR 72 , SR 72 , hetaryl, Het, optionally substituted with C 1-4 alkyl or CONH 2 ;
• R 7 is H, C 1-6 alkyl, (CH 2 ) 2 _ 4 R 7 1 1 or COOButyl;
• R 72 is H, C 1-6 -alkyl, optionally substituted with one or more OH;
• R 7 1 1 NR 7 1 1 1 R 7 1 1 2 Het or 1-imidazolyl, 2- (N-ethylpyrollidine);
• R 7 1 1 1 is H or C 1-6 alkyl; R 7 is 1 H 2 or C 1-6 alkyl;
• R a is a radical selected from the group consisting of aryl, C 7-11 -aralkyl and
• Heteroaryl which may optionally be substituted by one or more radicals selected from the group consisting of R 1 , R 2 and R 3 ;
• R 1 and R 2 are independently C 1-6 alkyl, C 2-6 alkenyl C 2-6 alkynyl, C 3-6 cycloalkyl, C 3-6 cycloalkenyl, C 1-6 haloalkyl, C 1 -6- alkylene-COOH, C 1-6 -alkoxy, halogen, OH, CN, COR 1 1 , OC 1-4 -haloalkyl, NO 2 or SR 1 1 , SOR 1 1 , SO 2 R 1 1 , Het or hetaryl,
• R 1 1 OH C 1-6 alkyl, C 2-6 alkenyl C 2-6 alkynyl, NR 1 1 1 R 1 1 2
• R 1 1 1 and R 1 1 2 together form a five- or six-membered heterocyclic ring which may optionally be substituted by a radical selected from the group consisting of methyl, ethyl, propyl;
• R 3 is a radical selected from the group consisting of
• X is bond or C 1-4 alkylene
• X ' is C 1-4 -alkylene, C 2-4 -alkenylene or C 1-4 -alkynylene
• R 3a is a radical, identical or different, selected from the group consisting of R 3 1 , R 32 and R 33 ;
• R 3 is spiro or het, wherein Het may optionally be substituted with one or more R 3 1 1 ;
• R 3 1 1 C 1-6 -alkyl, C 2-6 -alkenyl, OH, C 1-4 -alkylene-OH, C 1-4 -alkylene-NR 3 1 1 1 R 3 1 1 2 ', COR 3 1 1 1 , COOR 3 1 1 1 ,
• R 3 1 1 1 is a radical selected from the group consisting of H, C 1-4 alkyl, aryl and d-iralkyl; optionally substituted with a radical selected from the group consisting of halogen, OH and CN;
• R 3 1 1 2 H, C 1-4 alkyl
• R 32 is a radical selected from the group consisting of C 3-6 -cycloalkyl, het, hetaryl and spiro which is optionally substituted by one or more R 32 1 R 321 is C 1-6 alkyl, C 3-6 cycloalkyl, OH, NR 3211 R 3212 , NHCOR 3213 or Het optionally substituted with one or more radicals selected from the group consisting of C 1-4 alkyl, SO 2 R 3211 , CH 2 -C 3-6 cycloalkyl and aryl;
• R 3211 is H, C 1-4 alkyl or C 7-11 aralkyl
• R 3212 is H, C 1-4 alkyl or C 7-11 aralkyl
• R 3212 aryl, C 7-11 aralkyl or
• R 322 is C 1-6 alkyl, C 2-6 alkenyl, C 2-8 alkyl, COOR 3221 , CONR 3221 R 3222 , NR 3221 R 3222 , NHCOR 3221 , C 1-6 haloalkyl, CN, OR 3221 , SO 2 R 3221 , C 3-6 -cycloalkyl, CO-Het, C 2-4 -alkynyl-hetaryl, guanidine or a radical selected from the group consisting of Het, hetaryl and aryl, which is optionally substituted by one or more Radicals selected from the group halogen, C 1-6 -alkyl, CONR 3221 R 3222 , OH, imidazolidinone;
• R 3221 is H or C 1-6 alkyl, aryl, C 7-11 aralkyl
• R 3222 is H or C 1-6 alkyl
• Aryl optionally substituted with one or two R 323
• R 323 is a radical selected from the group consisting of NH-C 1-6 -alkyl-
• N is (C 1-6 alkyl) 2 or Het, wherein Het may optionally be substituted with a C 1-6 alkyl radical;
• H or a radical selected from the group consisting of C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 1-6 haloalkyl and aryl which may be optionally substituted with one or more radicals R 331 .
• R 331 C 3-6 cycloalkyl, C 3 _ 6 cycloalkenyl, OR 3311, NR 3311 R 3312, CONR 3311 R 3312, COOR 3311, NR 3311 3312 COR, SOR 3311, SO 2 R 33 1 1 , C (NR 33 1 1 R 33 1 2 ) NR 33 1 3 , NR 33 1 1 CONR 33 1 2 R 33 1 3 , OH, CN, halogen or Het, optionally substituted with one or more Radicals selected from the group consisting of C 1-4 alkyl, SO 2 H, SO 2 C 1-4 alkyl, SO 2 C 7-11 aralkyl, CH 2 -C 3-6 cycloalkyl and aryl;
• R 33 1 1 , R 33 1 2 and R 33 1 3 is a radical selected from the group consisting of C 1-6 -alkyl, C 2-6 -alkenyl, C 2-6 -alkynyl, C 7-11 -aralkyl, C 2-4 -alkenyl-aryl, C 2-4 -alkynyl-aryl, C 1-4 -alkyl-hetaryl, C 2-4 -alkenyl-hetaryl, C 2-4 -alkynyl-hetaryl,
• R 33 1 1 , R 3 3 1 2 and R 33 1 3 together form a ring consisting of carbon atoms and optionally one
• Heteroatom selected from the group consisting of oxygen, nitrogen and sulfur
• R a is H, Ci-8-alkyl, C 2-6 alkenyl, C 3-8 cycloalkyl, C 3-8 cycloalkenyl, C 1-6 haloalkyl, COR 8, NR 9 R 10, NO 2, OR 8 , SR 11 , SOR 11 , SO 2 R 11 , NHCO-C 1-6 alkyl-NH 2l spiro or a
• R 8 is C 1-6 alkyl, C 3-6 cycloalkyl, NH 2 , hetaryl or aryl optionally substituted with one or more halo or C 1-4 alkyl;
• R 9 is H, COOR 12 , CONR 12 or C 1-6 alkyl optionally substituted with one or more COOH, N (C 1-6 alkyl) 2 or Het optionally substituted with one or more C 1-6 alkyl ; or R 9 is het optionally substituted with one or more C 1-4 alkyl;
• R 1 0 H, C 1-6 alkyl, CO-C 1-6 alkyl or C 2-6 alkynyl;
• R 11 is C 1-6 alkyl optionally substituted with one or more N (C 1-4 alkyl) 2 ;
• R 12 is H, C 1-6 -alkyl
• R a is a radical selected from the group consisting of aryl, C 7-11 aralkyl and hetaryl, which may optionally be substituted by one or more radicals selected from the group consisting of R 1 , R 2 and R 3 ;
• R 1 and R 2 are independently C 1-6 alkyl, C 2-6 alkenyl C 2-6 alkynyl, C 3-6 cycloalkyl, C 3-6 cycloalkenyl, C 1-6 haloalkyl, C 1 -6- alkylene-COOH, C 1-6 -Aikoxy 1 halogen, OH, CN, COR 1 1 , OC 1-4 haloalkyl, NO 2 or SR 1 1 , SOR 1 1 , SO 2 R 1 1 , Het or hetaryl,
• R 1 1 OH C 1-6 alkyl, C 2-6 alkenyl C 2-6 alkynyl, NR 1 1 1 R 1 1 2
• R 1 1 2 H, C 1-6 alkyl
• R 1 1 1 and R 1 1 2 together form a five- or six-membered heterocyclic ring which may optionally be substituted by a radical selected from the group consisting of methyl, ethyl, propyl;
• R 3 is a radical selected from the group consisting of
• R 3a is a radical, identical or different, selected from the group consisting of R 31 , R 32 and R 33 ;
• R 31 is spiro or het, where Het may be optionally substituted with one or more R 311 ;
• R 311 is C 1-6 alkyl, C 2-6 alkenyl, OH, C 1-4 alkylene-OH, C 1-4 alkylene NR 3111 R 3112 , COR 3111 , COOR 3111 , CONR 3111 R 3112 , NR 3111 R 3112, Het, hetaryl, NHCOR 3111
• R 3111 is a radical selected from the group consisting of H, C 1-4 alkyl, aryl and C 7-11 aralkyl; optionally substituted with a radical selected from the group consisting of halogen, OH and CN;
• R 3112 is H, C 1-4 alkyl; a radical selected from the group consisting of C 3-6 -cycloalkyl, het, hetaryl and spiro which is optionally substituted by one or more R 321
• R 321 is C 1-6 alkyl, C 3-6 cycloalkyl, OH, NR 3211 R 3212 , NHCOR 3213 or
• Het optionally substituted with one or more radicals selected from the group consisting of C 1-4 alkyl, SO 2 R 3211 , CH 2 -C 3-6 cycloalkyl and aryl;
• R 3211 H 1 C 1-4 alkyl or C 7-11 aralkyl
• R 3212 is H, C 1-4 alkyl or C 7-11 aralkyl; R 3212 aryl, C 7-11 aralkyl; or
• R 322 is C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, COOR 3221 , CONR 3221 R 3222 , NR 3221 R 3222 , NHCOR 3221 , C 1-6 haloalkyl, CN, OR 3221 , SO 2 R 3221 , C 3-6 -cycloalkyl, CO-Het, C 2-4 -alkynyl-hetaryl, guanidine or a radical selected from the group consisting of Het, hetaryl and aryl, which is optionally substituted by one or more Radicals selected from the group halogen, C 1-6 -alkyl, CONR 3221 R 3222 , OH, imidazolidinone;
• R 3221 is H or C 1-6 alkyl, aryl, C 7-11 aralkyl R 3222 H or C 1-6 alkyl; or
• Aryl optionally substituted with one or two R 323
• R 323 is a radical selected from the group consisting of NH-C 1-6 -alkyl-N (C 1-6 -alkyl) 2 or Het, where Het may optionally be substituted by a radical C 1-6 -alkyl;
• R 33 is H or a radical selected from the group consisting of C 16 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 1-6 haloalkyl and aryl which may be optionally substituted by one or more radicals R 331 ;
• R 331 C 3-6 -cycloalkyl, C 3-6 -cycloalkenyl, OR 3311 , NR 3311 R 3312 ,
• CONR 3311 R 3312 COOR 3311 , NR 3311 COR 3312 , SOR 3311 , SO 2 R 3311 , C (NR 3311 R 3312 ) NR 3313 , NR 3311 CONR 3312 R 3313 , OH, CN, halogen or Het, optionally substituted with one or more radicals selected from the group consisting of C 1-4 alkyl, SO 2 H, SO 2 C 1-4 alkyl, SO 2 C 7-11 aralkyl,
• R 3311 , R 3312 and R 3313 are a radical selected from the group consisting of C 1-6 -alkyl, C 2-6 -alkenyl, C 2-6 -alkynyl, Cy-n-aralkyl, C 2-4 -alkenyl- Aryl, C 2-4 -alkynyl-aryl, C 1-4 -alkyl-
• a ring consisting of carbon atoms and optionally a heteroatom selected from the group consisting of oxygen, nitrogen and sulfur;
• R a is H, C 1-6 alkyl, C 2-6 alkenyl, C 3-8 cycloalkyl, C 3 _ 8 cycloalkenyl, C 1-6 haloalkyl, COR 8, NR 9 R 10, NO 2, OR 8 , SR 11 , SOR 11 , SO 2 R 11 , NHCO-C 1-6 -alkyl-NH 2 , spiro or a radical selected from the group consisting of C 7-11 -aralkyl, CH 2 -O-aryl and Het which may optionally be substituted with one or more halo, C 1-6 alkyl, CO-C 1-4 haloalkyl, C 1-4 alkyl-NH 2 or CH 2 NHCOOR 12 ;
• R 8 is C 1-6 alkyl, C 3-6 cycloalkyl, NH 2 , hetaryl or aryl optionally substituted with one or more halo or C 1-4 alkyl;
• R 9 is H, COOR 12 , CONR 12 or C 1-6 alkyl optionally substituted with one or more COOH, N (C 1-6 alkyl) 2 or Het optionally substituted with one or more C 1-6 alkyl ; or R 9 is het optionally substituted with one or more C 1-4 alkyl;
• R 10 is H, C 1-6 -alkyl, CO-C 1-6 -alkyl or C 2-6 -alkynyl;
• R 11 is C 1-6 alkyl optionally substituted with one or more N (C 1-4 alkyl) 2 ;
• R 12 is H, C 1-6 -alkyl
• R a is a radical selected from the group consisting of aryl, C 7- n -aralkyl and hetaryl, which may optionally be substituted by one or more radicals selected from the group consisting of R 1 , R 2 and R 3 ;
• R 1 and R 2 are independently C 1-6 alkyl, C 2-6 alkenyl C 2-6 alkynyl, C 3-6 cycloalkyl, C 3-6 cycloalkenyl, C 1-6 haloalkyl, C 1 -6- alkylene-COOH, C 1-6 -alkoxy, halogen, OH, CN, COR 1 1 , OC 1-4 -haloalkyl, NO 2 or SR 1 1 , SOR 1 1 , SO 2 R 1 1 , Het or hetaryl,
• R 1 1 OH C 1-6 alkyl, C 2-6 alkenyl C 2-6 alkynyl, NR 1 1 1 R 1 1 2
• R 3 is a radical selected from the group consisting of
• R 3a is a radical, identical or different, selected from the group consisting of R 3 1 , R 32 and R 33 ;
• R 3 is spiro or het, wherein Het may optionally be substituted with one or more R 3 1 1 ;
• R 3 1 1 C 1-6 -alkyl, C 2-6 -alkenyl, OH, C 1-4 -alkylene-OH, C 1-4 -alkylene-NR 3 1 1 1 R 3 1 1 2.
• COR 3 1 1 1 , COOR 3 1 1 1 , CONR 3 1 1 1 R 3 1 1 2 , NR 3 1 1 1 R 3 1 1 2 , Het, hetaryl, NHCOR 3 1 1 1 R 3111 is a radical selected from the group consisting of H, C 1-4 alkyl, aryl and C 7-11 aralkyl; optionally substituted with a radical selected from the group consisting of halogen, OH and CN;
• R 3112 is H, C 1-4 alkyl
• R 3 2 is a radical selected from the group consisting of C 3-6 -cycloalkyl, het, hetaryl and spiro which is optionally substituted by one or more R 3 21
• R 321 is C 1-6 alkyl, C 3-6 cycloalkyl, OH, -NR 3211 R 3212 , NHCOR 3213 or Het, optionally substituted with one or more radicals selected from the group consisting of C 1-4 alkyl, SO 2 R 3211 , CH 2 -C 3-6 cycloalkyl and aryl;
• R 3211 is H, C 1-4 alkyl or C 7-11 aralkyl
• R 3212 is H, C 1-4 alkyl or C 7-11 aralkyl
• R 3212 aryl, C 7-11 aralkyl or
• R 322 is C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, COOR 3221 , CONR 3221 R 3222 , NR 3221 R 3222 , NHCOR 3221 , C 1-6 haloalkyl, CN, OR 3221 , SO 2 R 3221 , C 3-6 -cycloalkyl, CO-Het, C 2-4 -alkynyl-hetaryl, guanidine or a radical selected from the group consisting of Het, hetaryl and aryl, which is optionally substituted by one or more Radicals selected from the group halogen, C 1-4 -alkyl, CONR 3221 R 3222 , OH, imidazolidinone;
• R 3221 H or C 1-6 alkyl, aryl, C 7-1 ! aralkyl
• R 3222 is H or C 1-6 alkyl
• Aryl optionally substituted with one or two R 323 R 323 is a radical selected from the group consisting of NH-C 1-6 -alkyl-N (C 1-6 -alkyl) 2 or Het, wherein Het may optionally be substituted by a radical C 1 6 -alkyl;
• R 33 is H or a radical selected from the group consisting of C 1-6 alkyl, C 2-4 alkenyl, C 2-4 alkynyl, C 1-4 haloalkyl and aryl which may be optionally substituted with one or more several radicals R 33 1 ;
• R 3 3 1 C 5-6 -cycloalkyl, C 1-6 -cycloalkenyl, OR 33 1 1 , NR 3 3 1 1 R 3 3 1 2 , CONR 3 3 1 1 R 3 3 1 2 , COOR 33 1 1 , NR 3 3 1 1 COR 3 3 1 2 , SOR 33 1 1 ,
• R 33 1 1 , R 33 1 2 and R 33 1 3 is a radical selected from the group consisting of C 1-4 -alkyl, C 2-4 -alkenyl, C 2-4 -alkynyl, C 7-11 -aralkyl, C 2-4 -alkenyl-aryl, C 2-4 -alkynyl-aryl, C 1-4 -alkyl-hetaryl, C 2-4 -alkenyl-hetaryl, C 2-4 -alkynyl-hetaryl,
• R 33 1 1 , R 3 3 1 2 and R 3 3 1 3 together form a five-, six- or seven-membered ring consisting of
• R 9 is H, COOR 12 or C 1-4 alkyl optionally substituted with one or more COOH, N (C 1-4 alkyl) 2 or Het optionally substituted with one or more C 1-4 alkyl; or R 9 is het optionally substituted with one or more C 1-4 alkyl;
• R 10 is H, C 1-6 -alkyl, CO-C 1-4 -alkyl or C 2-6 -alkynyl;
• R 11 is C 1-6 alkyl optionally substituted with one or more N (C 1-4 alkyl) 2 ;
• R 12 is C 1-6 alkyl
• R 4 is H, C 1-8 -alkyl, C 1-6 -haloalkyl, C 1-6 -alkylene-OH, C 2-6 -alkenyl, C 7 _n -aralkyl, C 2-4 -alkenyl-aryl, C 2 -4 alkynyl-aryl, C 1-4 alkyl hetaryl, hetaryl-C 2-4 alkenyl, C 2-4 alkynyl-hetaryl, C 2-6 alkynyl, optionally substituted by Si (C 1. 4, -Alkyl) 3 , or R 4 is a radical selected from the group consisting of aryl, het, hetaryl and optionally substituted by C 1-4 alkyl;
• R 5 is H or C 1-6 alkyl
• R 4 and R 5 together form a five, six or seven membered ring consisting of carbon atoms and optionally a heteroatom selected from the group consisting of oxygen, nitrogen and sulfur;
• R c NHR 6 or a radical selected from the group consisting of
• R 6 is H or a radical selected from the group consisting of C 1-4 -alkyl, C 2-4 -alkenyl, C 2-4 -alkynyl, C 3-6 -cycloalkyl, C 3-6 -cycloalkenyl, het, aryl, hetaryl optionally substituted with one or more R 61 ;
• R 61 is halogen, CF 3 , OH, CN, OMe, SO 2 (C 1-4 alkyl);
• R 7 is H, C 1-4 alkyl, C 2-4 alkenyl, C 2-4 alkynyl, C 3-6 cycloalkyl, NR 71 R 72 , OR 72 , SR 72 , hetaryl, Het optionally substituted with C 1-4 alkyl or CONH 2 ;
• R 71 is H, C 1-4 alkyl, (CH 2 ) 2 _ 4 R 711 or COOButyl;
• R 72 is H, C 1-6 -alkyl, optionally substituted with one or more OH;
• R 7i 1 NR 7111 R 7112 Het or 1-imidazolyl, 2- (N-ethylpyrollidine);
• R 7112 H or C 1-6 alkyl
• R a is a radical selected from the group consisting of aryl, C 7-11 aralkyl and hetaryl, which may optionally be substituted by one or more radicals selected from the group consisting of R 1 , R 2 and R 3 ;
• R 1 and R 2 are independently C 1-6 alkyl, C 2-6 alkenyl C 2-6 alkynyl, C 3-6 cycloalkyl, C 3-6 cycloalkenyl, C 1-6 haloalkyl, C 1 -6- alkylene-COOH, C 1-6 -alkoxy, halogen, OH, CN, COR 1 1 , OC 1-4 -haloalkyl, NO 2 or SR 1 1 , SOR 1 1 , SO 2 R 1 1 , Het or hetaryl,
• R 1 1 OH C 1-6 alkyl, C 2-6 alkenyl C 2-6 alkynyl, NR 1 1 1 R 1 1 2
• R 1 1 1 and R 1 1 2 together form a five- or six-membered heterocyclic ring which may optionally be substituted by a radical selected from the group consisting of methyl, ethyl, propyl;
• R 3 is a radical selected from the group consisting of
• R 3a is a radical, identical or different, selected from the group consisting of R 3 1 , R 32 and R 33 ;
• R 31 is spiro or het, where Het may be optionally substituted with one or more R 311 ;
• R 311 is C 1-6 -alkyl, C 2-6 -alkenyl, OH, C 1-4 -alkylene-OH, C 1-4 -alkylene-NR 3111 R 3112 , COR 3111 , COOR 3111 ,
• R 3111 is a radical selected from the group consisting of H, C 1-4 alkyl, aryl and C 7-11 aralkyl; optionally substituted with a radical selected from the group consisting of halogen, OH and CN;
• R 3112 is HC 1-4 alkyl
• R 32 is a radical selected from the group consisting of C 3-6 -cycloalkyl, het, hetaryl and spiro which is optionally substituted by one or more R 321
• R 321 is d- ⁇ -alkyl, C 3-6 -cycloalkyl, OH, -NR 3211 R 3212 , NHCOR 3213 or Het, optionally substituted with one or more radicals selected from the group consisting of C 1-4 alkyl, SO 2 R 3211 ,
• R 3211 is H, C 1-4 alkyl or C 7-11 aralkyl
• R 3212 is H, C 1-4 alkyl or C 7-11 aralkyl
• R 3212 aryl, C 7-11 aralkyl or
• R 322 is C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, COOR 3221 , CONR 3221 R 3222 , NR 3221 R 3222 , NHCOR 3221 , C 1-6 haloalkyl, CN, OR 3221 , SO 2 R 3221 , C 3-6 -cycloalkyl, CO-Het, C 2-4 -alkynyl-hetaryl, guanidine or a radical selected from the group consisting of Het, hetaryl and aryl, which is optionally substituted by one or more remains selected from the group halogen, C 1-6 alkyl, CONR 3221 R 3222 , OH, imidazolidinone;
• R 3221 H or C 1-6 alkyl, aryl, C 7 _ ir aralkyl 3222 R is H or C 1-6 alkyl; or
• Aryl optionally substituted with one or two R 323
• R 323 is a radical selected from the group consisting of NH-C 1-6 -alkyl-N (C 1-6 -alkyl) 2 or Het, where Het may optionally be substituted by a radical C 1-6 -alkyl;
• H or a radical selected from the group consisting of C 1-6 alkyl, C 2-4 alkenyl, C 2-4 alkynyl and aryl which may be optionally substituted with one or more R 331 radicals;
• R 331 Cs-e-cycloalkyl, C 5 - 6 cycloalkenyl, OR 3311, NR 3311 R 3312, CONR 3311 R 3312, 3311 COOR, COR NR 3311 3312, 3311 SOR, SO 2 R 3311, C (NR 3311 R 3312 ) NR 3313 , NR 3311 CONR 3312 R 3313 , OH, CN, halogen or Het, optionally substituted with one or more radicals selected from the group consisting of C 1-4 alkyl, SO 2 H, SO 2 -C 1-4 -Alkyl, SO 2 C 7 _n-aralkyl, CH 2 -C 3-6 -cycloalkyl and aryl;
• R 3311 , R 3312 and R 3313 is a radical selected from the group consisting of C 1-4 alkyl, C 7-11 aralkyl, C 1-4 alkyl hetaryl, COC 1-4 alkyl-H ⁇ taryl; or
• R a is H, C 1-6 alkyl, C 2-6 alkenyl, C 3-6 cycloalkyl, C 3-6 cycloalkenyl, Ci-8-haloalkyl, COR 8, NR 9 R 10, NO 2, OR 8 , SR 11 , SOR 11 , SO 2 R 11 , NHCO-C 1-6 -alkyl-NH 2l, spiro or a radical selected from the group consisting of C 7-11 -aralkyl, CH 2 -O-aryl and Het of optionally substituted with one or more halo, C 1-6 alkyl, CO-C 1-4 haloalkyl, C 1-4 alkyl-NH 2 or CH 2 NHCOOR 12 ;
• R 8 is C 1-6 alkyl, C 3-6 cycloalkyl, NH 2 , hetaryl or aryl optionally substituted with one or more halo or C 1-4 alkyl;
• R 9 is H, COOR 12 or C 1-4 alkyl optionally substituted with one or more COOH, N (C 1-4 alkyl) 2 or Het optionally substituted with one or more C 1-4 alkyl; or R 9 is het optionally substituted with one or more C 1-4 alkyl;
• R 10 is H, C 1-6 -alkyl, CO-C 1-4 -alkyl or C 2-6 -alkynyl;
• R 11 is C 1-6 alkyl optionally substituted with one or more N (C 1-4 alkyl) 2 ;
• R 12 is C 1-6 alkyl
• R b R 4 , OR 4 , -CH 2 OR 4 , COR 4 , COOR 4 , CONR 4 R 5 , NH 2 , NR 5 COOR 4 , NR 5 CONR 4 R 5 or NR 5 SOR 4 ;
• R 4 is H, C 1-6 alkyl, d -6 haloalkyl, C 1-6 -alkylene-OH, C 2-6 alkenyl, C 7-11 aralkyl, C 1 4 alkyl hetaryl, C 2 -6- alkynyl optionally substituted with Si (C 1-4 -alkyl) 3 , or R 4 represents a radical selected from the group consisting of aryl, het, hetaryl and optionally substituted by C 1-4 -alkyl;
• R 5 is H or d- ⁇ -alkyl
• R 4 and R 5 together form a five, six or seven membered ring consisting of carbon atoms and optionally a heteroatom selected from the group consisting of oxygen, nitrogen and sulfur; NHR 6 or a residue selected from the group consisting of
• R 6 is H or a radical selected from the group consisting of C 1-4 -alkyl, C 3-6 -cycloalkyl, het, aryl, hetaryl, optionally substituted by one or more radicals R 61 ;
• R 61 is halogen, CF 3 , OH, CN, OMe, SO 2 (C 1-4 alkyl);
• R 7 is H, C 1-4 alkyl, C 3-6 cycloalkyl, NR 71 R 72 , OR 72 , SR 72 , hetaryl, Het optionally substituted with C 1-4 alkyl or CONH 2 ;
• R 71 is H, C 1-4 alkyl, (CH 2 ) 2 _ 4 R 711 or COOButyl;
• R 72 is H, C 1-6 -alkyl, optionally substituted with one or more OH;
• R 711 NR 7111 R 7112 Het or 1-imidazolyl, 2- (N-ethylpyrollidine);
• R a is a radical selected from the group consisting of aryl and C 7-11 aralkyl, which may optionally be substituted by one or more radicals selected from the group consisting of R 1 , R 2 and R 3 ; or hetaryl optionally substituted by one or more C 1-4 alkyl;
• R 1 is C 1-4 -alkyl, C 1-4 -haloalkyl, C 1-4 -alkylene-COOH, C 1-4 -alkoxy, halogen, OH, CN, COR 1 1 , OC 1-4 -haloalkyl, NO 2 or SO 2 R 1 1 ;
• R 2 is C 1-4 alkyl, C 1-4 alkoxy or halo
• R 3 is a radical selected from the group consisting of
• R 3 is spiro or het, wherein Het may optionally be substituted with one or more R 3 1 1 ;
• R 3 1 1 C 1-4 -alkyl, C 2-4 -alkenyl, OH, C 1-4 -alkylene-OH, CH 2 NEt 2 , COMe, COOH, CONH 2 , NH 2 , Het, hetaryl,
• R 321 C 1-4 alkyl, cyclopentyl, OH, NR 3211 R 3212 or
• R 3211 is H, methyl or benzyl
• R 3212 is H, methyl or benzyl
• R 322 C 2-4 alkenyl, C 2-4 alkynyl, COOR 3221 , CONR 3221 R 3222 ,
• NR 3221 R 3222 NHCOR 3221 , C 1-4 haloalkyl, CN, OH, SO 2 R 3221 , C 3-6 cycloalkyl or a radical selected from the group consisting of
• R 3221 is H or methyl;
• R 3222 is H or methyl; or
• Aryl optionally substituted with one or two R 323
• R 331 radicals H or a radical selected from the group consisting of C 1-6 alkyl and aryl which may be optionally substituted with one or more R 331 radicals;
• R 331 C 5-6 -cycloalkyl, C 5 - 6 cycloalkenyl, OR 3311, NR 3311 R 3312, CONR 3311 R 3312, 3311 COOR, COR NR 3311 3312, 3311 SOR, SO 2 R 3311, C (NR 3311 R 3312 ) NR 3313 , NR 3311 CONR 3312 R 3313 , OH, CN, halogen or Het, optionally substituted with one or more radicals selected from the group consisting of methyl, SO 2 H, SO 2 C 1-4 -alkyl, 1 SO 2 C 7-11 -aralkyl,
• R 33 1 1 , R 33 1 2 and R 33 1 3 is a radical selected from the group consisting of C 1-4 -alkyl, C 7-11 -aralkyl, C 1-4 -alkyl-hetaryl, COC 1-4 alkyl hetaryl;
• R 8 is C 1-4 alkyl, C 3-6 cycloalkyl, NH 2 , furanyl or phenyl optionally substituted with one or more chloro;
• R 9 is H, COOR 12 or piperidino, optionally substituted by one or more CH 3 , or a radical selected from the group consisting of C 1-4 -alkyl, which may optionally be substituted by one or more COOH, NMe 2 or 4- methylpiperazine;
• R 10 is H, C 1-4 alkyl, C 2-4 alkynyl or COCH 3 ;
• R 11 is C 1-4 -alkyl, optionally substituted by one or more NMe 2 ,
• R 12 is C 1-4 alkyl
• R b R 4 , CH 2 OR 4 , COR 4 , COOR 4 , CONR 4 R 5 , NH 2 , NHCOOR 4 , NHCONR 4 R 5 or OH;
• R 4 is H, C 1-4 -alkyl, C 1-4 -alkylene-OH, C 2-4 -alkynyl, C 1-6 -haloalkyl, aryl, het, hetaryl,
• R c M NHR 6 or a radical selected from the group consisting of
• R 6 is H, C 1-4 alkyl, C 3-6 cycloalkyl, C 7-11 aralkyl, aryl optionally substituted with SO 2 CH 3 ;
• R 7 is H, NR 71 R 72 , OR 72 , SR 72 , hetaryl, Het, optionally substituted by C 1-4 alkyl or CONH 2 , or a radical selected from the group consisting of
• R 71 is H, C 1-4 alkyl, (CH 2 ) 2 R 711 or COOButyl;
• R 72 is H, C 1-4 alkyl;
• R 711 NR 7111 R 7112 Het or 1-imidazolyl, 2- (N-ethylpyrollidine);
• R a is phenyl or benzyl, each optionally substituted by one or more radicals selected from the group consisting of R 1 , R 2 and R 3 ; or
• R 1 is methyl, ethyl, propyl, butyl, CF 3, CH 2 COOH, methoxy, F, Cl, Br, OH, CN, COR 1 1, OCF 3, NO 2 or SO 2 R 1 1;
• R 2 is methyl, methoxy, F, Cl or Br
• R 3 is a radical selected from the group consisting of
• R 3 1 is a radical selected from the group consisting of
• R 32 is 1 H, methyl or benzyl; R 32 is H 2 , methyl or benzyl; or C 1-6 alkyl, straight or branched, which is optionally substituted with one or two R 322 ;
• R 322 C CH 2 , C ⁇ CH, COOR 3221 , CONR 3221 R 3222 , NR 3221 R 3222 ,
• NHCOR 3221 CF 3 , CN, OH, SO 2 R 3221 or a radical selected from the group consisting of
• R 3221 is H or methyl
• R 3222 is H or methyl
• R 323 is a radical selected from the group consisting of
• R 331 Cs-e-cycloalkyl, C 5 - 6 cycloalkenyl, OR 3311, NR 3311 R 3312, CONR 3311 R 3312, 3311 COOR, COR NR 3311 3312, 3311 SOR, SO 2 R 3311, C (NR 3311 R 3312 ) NR 3313 , NR 3311 CONR 3312 R 3313 , OH, CN, halogen or Het which is optionally substituted by one or more radicals selected from the group consisting of
• R 3311 , R 3312 and R 3313 are a radical selected from the group consisting of C 1-4 -alkyl, C 7-11 -aralkyl, C 1-4 -alkyl-hetaryl, COC 1-4 -alkyl-hetaryl; H, methyl, ethyl, propyl, butyl, 3-methyl-butyl, propenyl, cyclopropyl, cyclohexyl, CF 3 , COR 8 , NR 9 R 10 , NO 2 , OR 8 , SR 11 , SOR 11 , SO 2 R 11 or a residue selected from the group consisting of
• R 8 is methyl, propyl, cyclopropyl, NH 2 , furanyl or phenyl optionally substituted with one or more chloro;
• R 9 is H, COOR 12 or piperidino, optionally substituted with one or more CH 3 , or a radical selected from the group consisting of methyl, ethyl and propyl, which may be optionally substituted with one or more COOH, NMe 2 or 4-methylpiperazine ;
• R 11 is ethyl or propyl, optionally substituted by one or more NMe 2 ,
• R b R 4 , CH 2 OR 4 , COR 4 , COOR 4 , CONR 4 R 5 , NH 2 , NHCOOR 4 , NHCONR 4 R 5 or OH;
• R 4 is H, methyl, ethyl, 2-hydroxyethyl, propyl, C 1 H 3 , CF 3 , phenyl,
• R 5 is H, methyl or ethyl
• B bond methylene, ethylene, propylene or butynylene
• R 6 is H, C 1-4 alkyl, aryl, optionally substituted with SO 2 CH 3 ;
• R 7 H NR 7 1 R 7 2 , OR 7 2 , SR 7 2 or a radical selected from the group consisting of
• R 7 is H, methyl, ethyl, (CH 2 ) 2 R 7 1 1 or COOButyl;
• R 72 is H, methyl or ethyl;
• R 7 1 1 NR 7 1 1 1 R 7 1 1 2 Het or 1-imidazolyl, 2- (N-ethylpyrollidine);
• R 7 1 1 1 is H or C 1-6 alkyl; R 7 is 1 H 2 or C 1-6 alkyl;
• R a is a radical selected from the group consisting of aryl, C 7-11 aralkyl and hetaryl, which may optionally be substituted by one or more radicals selected from the group consisting of R 1 , R 2 and R 3 ;
• R 1 and R 2 are independently C 1-6 alkyl, C 2-6 alkenyl C 2-6 alkynyl, C 3-6 cycloalkyl, C 3-6 cycloalkenyl, C 1-6 haloalkyl, C 1 -6- alkylene-COOH, C 1-6 -alkoxy, halogen, OH, CN, COR 1 1 , OC 1-4 -haloalkyl, NO 2 or SR 1 1 , SOR 1 1 , SO 2 R 1 1 , Het or hetaryl,
• R 1 1 1 and R 1 1 2 together form a five- or six-membered heterocyclic ring which may optionally be substituted by a radical selected from the group consisting of methyl, ethyl, propyl;
• R 3a is a radical, identical or different, selected from the group consisting of R 3 1 , R 32 and R 33 ;
• R 3 is spiro or het, wherein Het may optionally be substituted with one or more R 3 1 1 ;
• R 311 is C 1-6 alkyl, C 2-6 alkenyl, OH, C 1-4 alkylene-OH, C 1-4 alkylene NR 3111 R 3112 , COR 3111 , COOR 3111 , CONR 3111 R 3112 , NR 3111 R 3112, Het, hetaryl, NHCOR 3111
• R 3111 is a radical selected from the group consisting of H, C 1-4 alkyl, aryl and C 7-11 aralkyl; optionally substituted with a radical selected from the group consisting of halogen, OH and CN;
• R 3112 is H, C 1-4 alkyl
• R 321 is C 1-6 alkyl, C 3-6 cycloalkyl, OH, NR 3211 R 3212 , NHCOR 3213 or
• Het optionally substituted with one or more radicals selected from the group consisting of C 1-4 alkyl, SO 2 R 3211 , CH 2 -C 3-6 cycloalkyl and aryl;
• R 3211 H 1 C 1-4 alkyl or C 7-11 aralkyl
• R 3212 is H, C 1-4 alkyl or C 7-11 aralkyl; R 3212 aryl, C 7-11 aralkyl; or
• R 322 is C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, COOR 3221 , CONR 3221 R 3222 , NR 3221 R 3222 , NHCOR 3221 , C 1-6 haloalkyl, CN, OR 3221 , SO 2 R 3221 , C 3-6 -cycloalkyl, CO-Het, C 2-4 -alkynyl-hetaryl, guanidine or a radical selected from the group consisting of Het, hetaryl and aryl, which is optionally substituted by one or more Radicals selected from the group halogen, C 1-6 -alkyl, CONR 3221 R 3222 , OH, imidazolidinone;
• R 3221 is H or C 1-6 alkyl, aryl, C 7-11 aralkyl
• R 3222 is H or C 1-6 alkyl
• Aryl optionally substituted with one or two R 323
• R 323 is a radical selected from the group consisting of NH-C 1-6 -alkyl-
• N is (C 1-6 alkyl) 2 or Het, wherein Het may optionally be substituted with a C 1-6 alkyl radical;
• H or a radical selected from the group consisting of C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 1-6 haloalkyl and aryl which may be optionally substituted with one or more radicals R 331 ;
• R 331 C 3-6 cycloalkyl, C 3-6 cycloalkenyl, OR 3311 , NR 3311 R 3312 , CONR 3311 R 3312 , COOR 3311 , NR 3311 COR 3312 , SOR 3311 , SO 2 R 3311 , C (NR 3311 R 3312 ) NR 3313 , NR 3311 CONR 3312 R 3313 , OH,
• CN halogen or Het optionally substituted with one or more radicals selected from the group consisting of C 1-4 alkyl, SO 2 R 3211 , SO 2 C 1-4 alkyl, SO 2 C 7-11 aralkyl, CH 2 -C 3-6 -cycloalkyl and aryl;
• R 3311 , R 3312 and R 3313 is a radical selected from the group consisting of C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 7-11 aralkyl, C 2-4 alkenyl -Aryl, C 2-4 -alkynyl-aryl, C 1-4 -alkyl-hetaryl, C 2-4 -alkenyl-hetaryl, C 2-4 -alkynyl-hetaryl, COC 1-4 -alkyl-hetaryl, COC 2 -4 alkenyl-hetaryl,
• R 3311 , R 3312 and R 3313 together form a ring consisting of carbon atoms and optionally a heteroatom selected from the group consisting of oxygen,
• R 4 is H, C 1-6 alkyl, C 1-6 haloalkyl, C 1-6 -alkylene-OH, C 2-6 alkenyl, C 7 _ ir aralkyl, C 2-4 alkenyl Aryl, C 2-4 -alkynyl-aryl, C 1-4 -alkyl-hetaryl, C 2-4 -alkenyl-hetaryl, C 2-4 -alkynyl-hetaryl, C 2-6 -alkynyl, optionally substituted by Si ( C 1-4 alkyl) 3 , or R 4 is a radical selected from the group consisting of aryl, het, hetaryl and optionally substituted by C 1-4 alkyl;
• R 4 and R 5 together form a five, six or seven membered ring consisting of carbon atoms and optionally a heteroatom selected from the group consisting of oxygen, nitrogen and sulfur;
• R c NHR 6 or a radical selected from the group consisting of
• B bond C 1-6 alkyl, C 2-6 alkenyl or C 2-6 alkynyl;
• R 6 is H or a group selected from the group C 1 -C 4 alkyl, C 2-4 alkenyl, C 2-4 alkynyl, C 3-6 cycloalkyl, C 3-6 cycloalkenyl, het, aryl, hetaryl optionally substituted with one or more R 6 1 ;
• R 6 1 is halogen, CF 3 , OH, CN, OMe, SO 2 (C 1-4 alkyl);
• R 7 is H, C 1-4 alkyl, C 2-4 alkenyl, C 2-4 alkynyl, C 3-6 cycloalkyl, NR 7 1 R 72 , OR 72 , SR 72 , hetaryl, Het, optionally substituted C 1 4 alkyl or CONH 2;
• R 7 is H, C 1-6 -alkyl, (CH 2 ) 2 . 4 R 7 1 1 or COOButyl;
• R 72 is H, C 1-6 -alkyl, optionally substituted with one or more OH;
• R 7 1 1 NR 7 1 1 1 R 7 1 1 2 Het or 1-imidazolyl, 2- (N-ethylpyrollidine);
• R 7 1 1 1 is H or C 1-6 alkyl; R 7 is 1 H 2 or C 1-6 alkyl;
• R a is a radical selected from the group consisting of aryl, dn-aralkyl and hetaryl, which may optionally be substituted by one or more radicals selected from the group consisting of R 1 , R 2 and R 3 ;
• R 1 and R 2 are independently C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-6 cycloalkyl, C 3 _ 6 cycloalkenyl, C 1-6 -haloalkyl, C 1 -6- alkylene-COOH, C 1-6 -Aikoxy 1 halogen, OH, CN, COR 1 1 , OC 1-4 haloalkyl, NO 2 or SR 1 1 , SOR 1 1 , SO 2 R 1 1 , Het or hetaryl,
• R 1 1 OH C 1-6 alkyl, C 2-6 alkenyl C 2-6 alkynyl, NR 1 1 1 R 1 1 2
• R 1 1 1 and R 1 1 2 together form a five- or six-membered heterocyclic ring which may optionally be substituted by a radical selected from the group consisting of methyl, ethyl, propyl;
• R 3 is a radical selected from the group consisting of
• R 3a is a radical, identical or different, selected from the group consisting of R 31 , R 32 and R 33 ;
• R 31 is spiro or het, where Het may be optionally substituted with one or more R 311 ;
• R 311 is C 1-6 alkyl, C 2-6 alkenyl, OH, C 1-4 alkylene-OH, C 1-4 alkylene NR 3111 R 3112 , COR 3111 , COOR 3111 , CONR 3111 R 3112 , NR 3111 R 3112, Het, hetaryl, NHCOR 3111
• R 3111 is a radical selected from the group consisting of H, C 1-4 alkyl, aryl and C 7-11 aralkyl; optionally substituted with a radical selected from the group consisting of halogen, OH and CN;
• R 3112 is H, C 1-4 alkyl; a radical selected from the group consisting of C 3-6 -cycloalkyl, het, hetaryl and spiro which is optionally substituted by one or more R 321
• R 321 C 1-6 alkyl, C 3-6 cycloalkyl, OH , - NR 3211 R 3212 , NHCOR 3213 or
• Het optionally substituted with one or more radicals selected from the group consisting of C 1-4 alkyl, SO 2 R 3211 , CH 2 -C 3-6 cycloalkyl and aryl;
• R 3211 H 1 C 1-4 alkyl or C 7-11 aralkyl
• R 3212 is H, C 1-4 alkyl or C 7-11 aralkyl; R 3212 aryl, C 7-11 aralkyl; or
• R 322 is C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, COOR 3221 , CONR 3221 R 3222 , NR 3221 R 3222 , NHCOR 3221 , C 1-6 haloalkyl, CN, OR 3221 , SO 2 R 3221 , C 3-6 -cycloalkyl, CO-Het, C 2-4 -alkynyl-hetaryl, guanidine or a radical selected from the group consisting of Het, hetaryl and aryl, which is optionally substituted by one or more Radicals selected from the group halogen, C 1-6 -alkyl, CONR 3221 R 3222 , OH, imidazolidinone;
• R 3221 is H or C 1-6 alkyl, aryl, C 7-11 aralkyl R 3222 H or C 1-6 alkyl; or
• Aryl optionally substituted with one or two R 323
• R 323 is a radical selected from the group consisting of NH-C 1-6 -alkyl-N (C 1-6 -alkyl) 2 or Het, where Het may optionally be substituted by a radical C 1-6 -alkyl;
• R 33 is H or a radical selected from the group consisting of C 1-6 alkyl, C 2-4 alkenyl, C 2-4 alkynyl, C 1-4 haloalkyl and aryl which may be optionally substituted with one or more several residues R 331 ;
• R 331 C 5 - 6 cycloalkyl, C 5 - 6 cycloalkenyl, OR 3311, NR 3311 R 3312,
• CONR 3311 R 3312 COOR 3311 , NR 3311 COR 3312 , SOR 3311 , SO 2 R 3311 , C (NR 3311 R 3312 ) NR 3313 , NR 3311 CONR 3312 R 3313 , OH, CN, halogen or Het, optionally substituted with one or more radicals selected from the group consisting of C 1-4 -alkyl, SO 2 R 3211 , SO 2 C 1-4 -alkyl, SO 2 C 7-11 -aralkyl,
• R 3311 , R 3312 and R 3313 is a radical selected from the group consisting of C 1-4 alkyl, C 2-4 alkenyl, C 2-4 alkynyl, C 7-11 aralkyl, C 2-4 alkenyl -Aryl, C 2-4 -alkynyl-aryl, C 1-4 -alkyl-
• R 3311 , R 3312 and R 3313 together form a five, six or seven membered ring consisting of carbon atoms and optionally a heteroatom selected from the group consisting of oxygen, nitrogen and sulfur;
• R 4 is H, C 1-6 -alkyl, C 1-6 -haloalkyl, C 1-6 -alkylene-OH, C 2-6 -alkenyl, C 7-11 -aralkyl, C 2-4 -alkenyl-aryl, C 2-4 -alkynyl-aryl, C 1-4 -alkyl-hetaryl, C 2-4 -alkenyl-hetaryl, C 2-4 -alkynyl-hetaryl, C 2-6 -alkynyl, optionally substituted by Si (C 1 -4- alkyl) 3 , or R 4 is a radical selected from the group consisting of aryl, het, hetaryl and optionally substituted by C 14 alkyl; R 5 is H or C 1-6 alkyl;
• R 4 and R 5 together form a five, six or seven membered ring consisting of carbon atoms and optionally a heteroatom selected from the group consisting of oxygen, nitrogen and sulfur;
• R c NHR 6 or a radical selected from the group consisting of
• R 6 is H or a radical selected from the group consisting of C 1-4 -alkyl, C 2-4 -alkenyl, C 2-4 -alkynyl, C 3-6 -cycloalkyl, C 3-6 -cycloalkenyl, het, aryl, hetaryl optionally substituted with one or more R 6 1 ;
• R 6 1 is halogen, CF 3 , OH, CN, OMe, SO 2 (C 1-4 alkyl);
• R 7 is H, C 1-4 alkyl, C 2-4 alkenyl, C 2-4 alkynyl, C 3-6 cycloalkyl, NR 7 1 R 72 , OR 72 , SR 72 , hetaryl, Het, optionally substituted with C 1-4 alkyl or CONH 2 ;
• R 7 is H, C 1-4 alkyl, (CH 2 ) 2 _ 4 R 7 1 1 or COOButyl;
• R 72 is H, C 1-6 -alkyl, optionally substituted with one or more OH;
• R 7 1 1 NR 7 1 1 1 R 7 1 1 2 Het or 1-imidazolyl, 2- (N-ethylpyrollidine);
• R 7 1 1 1 is H or C 1-6 alkyl; R 7 is 1 H 2 or C 1-6 alkyl; and pharmacologically acceptable salts, diastereomers, enantiomers, racemates, hydrates or solvates thereof.
• R a is a radical selected from the group consisting of aryl, Cy.-n-aralkyl and
• Hetaryl which may optionally be substituted by one or more radicals selected from the group consisting of R 1 , R 2 and R 3 ;
• R 1 and R 2 are independently C 1-6 alkyl, C 2-6 alkenyl C 2-6 alkynyl, C 3-6 cycloalkyl, C 3-6 cycloalkenyl, C 1-6 haloalkyl, C 1 -6- alkylene-COOH, C 1-6 -alkoxy, halogen, OH, CN, COR 1 1 , OC 1-4 -haloalkyl, NO 2 or SR 1 1 , SOR 1 1 , SO 2 R 1 1 , Het or hetaryl,
• R 1 1 OH C 1-6 alkyl, C 2-6 alkenyl C 2-6 alkynyl, NR 1 1 1 R 1 1 2
• R 1 1 1 and R 1 1 2 together form a five- or six-membered heterocyclic ring which may optionally be substituted by a radical selected from the group consisting of methyl, ethyl, propyl;
• R 3 is a radical selected from the group consisting of
• R 3a is a radical, identical or different, selected from the group consisting of R 31 , R 32 and R 33 ;
• R 31 is spiro or het, where Het may be optionally substituted with one or more R 311 ;
• R 311 is C 1-6 alkyl, C 2-6 alkenyl, OH, C 1-4 alkylene-OH, C 1-4 alkylene NR 3111 R 3112 , COR 3111 , COOR 3111 , CONR 3111 R 3112 , NR 3111 R 3112, Het, hetaryl, NHCOR 3111
• R 3111 is a radical selected from the group consisting of H, C 1-4 alkyl, aryl and C 7-11 aralkyl; optionally substituted with a radical selected from the group consisting of halogen, OH and CN; R 3112 is H, C 1-4 alkyl;
• R 32 is a radical selected from the group consisting of C 3-6 -cycloalkyl, het, hetaryl and spiro which is optionally substituted by one or more R 321
• R 321 is C 1-6 alkyl, C 3-6 cycloalkyl, OH, -NR 3211 R 3212 , NHCOR 3213 or
• Het optionally substituted with one or more radicals selected from the group consisting of C 1-4 alkyl, SO 2 R 3211 , CH 2 -C 3-6 cycloalkyl and aryl;
• R 3211 H, C 1-4 alkyl or C 7-11 aralkyl
• R 3212 is H, C 1-4 alkyl or C 7-11 aralkyl; R 3212 aryl, C 7-11 aralkyl; or
• R 322 is C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, COOR 3221 , CONR 3221 R 3222 , NR 3221 R 3222 , NHCOR 3221 , C 1-6 haloalkyl, CN, OR 3221 , SO 2 R 3221 , C 3-6 -cycloalkyl, CO-Het, C 2-4 -alkynyl-hetaryl, guanidine or a radical selected from the group consisting of Het, hetaryl and aryl, which is optionally substituted by one or more Radicals selected from the group halogen, C 1-6 -alkyl, CONR 3221 R 3222 , OH, imidazolidinone;
• R 3221 HoderC 1-6 alkyl, aryl, C 7 -i rAralkyl
• R 3222 is H or C 1-6 alkyl
• Aryl optionally substituted with one or two R 323
• R 323 is a radical selected from the group consisting of NH-C 1-6 -alkyl-
• N is (C 1-6 alkyl) 2 or Het, wherein Het may optionally be substituted with a C 1-6 alkyl radical;
• H or a radical selected from the group consisting of C 1-6 alkyl, C 2-4 alkenyl, C 2-4 alkynyl and aryl which may be optionally substituted with one or more R 331 radicals;
• R 331 C 5-6 -cycloalkyl, C 5 - 6 cycloalkenyl, OR 3311, NR 3311 R 3312, CONR 3311 R 3312, 3311 COOR, COR NR 3311 3312, 3311 SOR, SO 2 R 3311, C (NR 3311 R 3312 ) NR 3313 , NR 3311 CONR 3312 R 3313 , OH,
• CN halogen or Het optionally substituted by one or more radicals selected from the group consisting of C 1-4 alkyl, SO 2 R 3211 , SO 2 C 1-4 alkyl, SO 2 C 7-11 aralkyl, CH 2 -C 3-6 -cycloalkyl and aryl;
• R 3311 , R 3312 and R 3313 is a radical selected from the group consisting of C 1-4 -alkyl, C 7-11 -aralkyl, C 1-4 -alkyl-hetaryl, C0C 1-4 -alkyl-hetaryl; or two of the groups R 33 1 1 , R 33 1 2 and R 33 1 3 together form a five, six or seven membered ring consisting of carbon atoms and optionally a heteroatom selected from the group consisting of oxygen, nitrogen and sulfur;
• R b R 4 , OR 4 , -CH 2 OR 4 , COR 4 , COOR 4 , CONR 4 R 5 , NH 2 , NR 5 COOR 4 , NR 5 CONR 4 R 5 or NR 5 SOR 4 ;
• R 4 is H, C 1-6 alkyl, C 1-6 haloalkyl, C 1-6 -alkylene-OH, C 2-6 alkenyl, C 7-11 aralkyl, C 1 4 alkyl
• R 5 is H or C 1-6 alkyl
• R 4 and R 5 together form a five, six or seven membered ring consisting of carbon atoms and optionally a heteroatom selected from the group consisting of oxygen, nitrogen and sulfur;
• R c NHR 6 or a radical selected from the group consisting of
• R 6 is H or a radical selected from the group consisting of C 1-4 -alkyl, C 3-6 -cycloalkyl, het, aryl, hetaryl, optionally substituted by one or more radicals R 6 1 ;
• R 7 is H, C 1-4 alkyl, C 3-6 cycloalkyl, NR 7 1 R 72 , OR 72 , SR 72 , hetaryl, Het optionally substituted with C 1-4 alkyl or CONH 2 ;
• R 7 is H, C 1-4 alkyl, (CH 2 ) 2-4 R 7 1 1 or COOButyl;
• R 72 is H, C 1-6 -alkyl, optionally substituted with one or more OH;
• R 7 1 1 NR 7 1 1 1 R 7 1 1 2 Het or 1-imidazolyl, 2- (N-ethylpyrollidine);
• R 7 1 1 1 is H or C 1-6 alkyl
• R 7 is 1 H 2 or C 1-6 alkyl
• R a is a radical selected from the group consisting of aryl and C 7-11 aralkyl, which may optionally be substituted by one or more radicals selected from the group consisting of R 1 , R 2 and R 3 ; or hetaryl optionally substituted by one or more C 1-4 alkyl;
• R 1 is C 1-4 -alkyl, C 1-4 -haloalkyl, C 1-4 -alkylene-COOH, C 1-4 -alkoxy, halogen, OH, CN, COR 1 1 , OC 1-4 -haloalkyl, NO 2 or SO 2 R 1 1 ;
• R 3 is spiro or het, wherein Het may optionally be substituted with one or more R 3 1 1 ;
• R 3 1 1 C 1-4 -alkyl, C 2-4 -alkenyl, OH, C 1-4 -alkylene-OH, CH 2 NEt 2 , COMe, COOH, CONH 2 , NH 2 , Het, hetaryl,
• R is a radical selected from the group consisting of C 3-6 -cycloalkyl, het, hetaryl and spiro which is optionally substituted by one or two
• R 32 is C 1-4 -alkyl, cyclopentyl, OH, -NR 32 1 1 R 3 2 1 2 or
• R 3211 is H, methyl or benzyl
• R 3212 is H, methyl or benzyl
• R 322 C 2-4 alkenyl, C 2-4 alkynyl, COOR 3221 , CONR 3221 R 3222 ,
• NR 3221 R 3222 NHCOR 3221 , C 1-4 haloalkyl, CN, OH, SO 2 R 3221 , C 3-6 cycloalkyl or a radical selected from the group consisting of
• R 3221 is H or methyl; R 3222 is H or methyl; or Aryl optionally substituted with one or two R 323
• R 323 is a radical selected from the group consisting of
• R 33 is H or a radical selected from the group consisting of C 1-6 -alkyl and aryl, which may optionally be substituted by one or more radicals R 331 ;
• R 331 C 5-6 -cycloalkyl, C 5 - 6 cycloalkenyl, OR 3311, NR 3311 R 3312, CONR 3311 R 3312, 3311 COOR, COR NR 3311 3312, 3311 SOR, SO 2 R 3311, C (NR 3311 R 3312 ) NR 3313 , NR 3311 CONR 3312 R 3313 , OH, CN, halogen or Het, optionally substituted by one or more radicals selected from the group consisting of C 1-4 alkyl, SO 2 R 3211 , SO 2 C 1- 4- alkyl, SO 2 C 7-11 -aralkyl,
• R 3311 , R 3312 and R 3313 are a radical selected from the group consisting of C 1-4 -alkyl, C 7-11 -aralkyl, C 1-4 -alkyl-hetaryl, COC 1-4 -alkyl-hetaryl;
• R b R 4 , CH 2 OR 4 , COR 4 , COOR 4 , CONR 4 R 5 , NH 2 , NHCOOR 4 , NHCONR 4 R 5 or OH;
• R 4 is H, C 1-4 -alkyl, C 1-4 -alkylene-OH, C 2-4 -alkynyl, C 1-6 -haloalkyl, aryl, het, hetaryl,
• NHR 6 or a residue selected from the group consisting of
• R 6 is H, C 1-4 alkyl, C 3-6 cycloalkyl, C 7-11 aralkyl, aryl optionally substituted with SO 2 CH 3 ;
• R 7 is H, NR 71 R 72 , OR 72 , SR 72 , hetaryl, Het, optionally substituted by C 1-4 alkyl or CONH 2 , or a radical selected from the group consisting of
• R 71 is H, C 1-4 alkyl, (CH 2 ) 2 R 711 or COOButyl;
• R 72 is H, C 1-4 alkyl;
• R 7111 is H or C 1-6 alkyl; R 7112 H or C 1-6 alkyl; and pharmacologically acceptable salts, diastereomers, enantiomers, racemates, hydrates or solvates thereof.
• R a is phenyl or benzyl, each optionally substituted by one or more radicals selected from the group consisting of R 1 , R 2 and R 3 ; or
• R 1 is methyl, ethyl, propyl, butyl, CF 3, CH 2 COOH, methoxy, F, Cl, Br, OH, CN, COR 1 1, OCF 3, NO 2 or SO 2 R 1 1;
• R 2 is methyl, methoxy, F, Cl or Br
• R 3 is a radical selected from the group consisting of wherein n is 0 or 1; m is 0 or 1; o 2;
• R 3 1 is a radical selected from the group consisting of
• R 3 1 1 which may optionally be substituted by one or more R 3 1 1 .
• R 3 1 1 methyl, ethyl, OH, CH 2 OH, CH 2 CH 2 OH, CH 2 NEt 2 , COMe, COOH, CONH 2 , NH 2 ,
• R 3211 is H, methyl or benzyl
• R 3212 is H, methyl or benzyl
• R 322 C CH 2 , C ⁇ CH, COOR 3221 , CONR 3221 R 3222 , NR 3221 R 3222 ,
• NHCOR 3221 CF 3, CN, OH, SO 2 R 3221 or a radical selected from the group consisting of
• R 3221 is H or methyl;
• R 3222 is H or methyl; or
• R is a radical selected from the group consisting of
• R 5 is H, methyl or ethyl
• R c is NH 2 or a radical selected from the group consisting of
• B bond methylene, ethylene, propylene or butynylene
• R 6 is H, phenyl optionally substituted with SO 2 CH 3 ;
• R 7 H NR 7 1 R 72 , OR 72 , SR 72 or a radical selected from the group consisting of
• R 7 is H, methyl, ethyl, (CH 2 ) 2 R 7 1 1 or COOButyl;
• R 72 is H, methyl or ethyl;
• B is methylene, propylene
• R 7 is H, NR 7 1 R 7 2 or 1 -imidazolyl
• R 7 is H or methyl
• R 72 is H or methyl
• R a is phenyl, optionally substituted by one or more radicals selected from the group consisting of R 1 , R 2 and R 3 ; and pharmacologically acceptable salts, diastereomers, enantiomers, racemates, hydrates or solvates thereof.
• R a is phenyl, optionally substituted by one or more radicals selected from the group consisting of R 1 and R 3 ;
• R 1 is methyl, ethyl, propyl, CF 3 , methoxy, F, Cl or Br;
• R 3 is a remainder
• R a is phenyl, optionally substituted by one or more radicals selected from the group consisting of R 1 and R 3 ;
• R 1 is methyl, ethyl, propyl, CF 3 , methoxy, F, Cl or Br;
• R 3 is a remainder
• R a , R b and R c have the abovementioned meaning, as well as pharmacologically acceptable salt, diastereomers, enantiomers, racemates, hydrates or solvates thereof.
• R a is phenyl, optionally substituted by one or more radicals selected from the group consisting of R 1 , R 2 and R 3 ; or
• R 1 is methyl, ethyl, propyl, CF 3 , CH 2 COOH, methoxy, F, Cl, Br, CN, COR 1 1 or SO 2 R 11 ;
• R 1 1 OH, methyl, NH 2, NHMe, NMe 2, or
• R 2 is methyl, F, Cl or Br
• R 3 is a radical selected from the group consisting of
• R is a radical selected from the group consisting of
• R 3 1 may be the optionally substituted with one or more R, 3 1.
• R 3 1 1 methyl, OH, CH 2 OH, CH 2 CH 2 OH, CH 2 NEt 2 , COMe, COOH, CONH 2 ,
• R 3211 is H or methyl
• R 3212 is H or methyl
• R 322 C CH 2 , C ⁇ CH, COOR 3221 , CONR 3221 R 3222 , NR 3221 R 3222 , CN, OH or a radical selected from the group consisting of
• R 32 is 2 H or methyl; R 322 is 2 H or methyl; or
• R 3 23 is a radical selected from the group consisting of
• R 3 is H, methyl or ethyl
• R b CH 2 OCH 3 , COR 4 , COOH, COOCH 3 CONR 4 R 5 , NH 2, NHCOOR 4 or OH;
• R 4 is H, methyl, propyl, C 1 H 6, phenyl,
• R 5 is H or methyl
• B is methylene, propylene;
• R 7 is H, NR 7 1 R 72 or 1 -imidazolyl;
• R 7 is H or methyl
• R 72 is H or methyl
• R a is phenyl, optionally substituted by one or more radicals selected from the group consisting of R 1 , R 2 and R 3 ; or
• R 1 is methyl, CF 3 , methoxy, F, Cl, Br, COR 1 1 or SO 2 R 1 1 ;
• R 1 1 is OH, NH 2, NHMe or NMe 2;
• R 3 is a radical selected from the group consisting of
• R 3 1 is a radical selected from the group consisting of
• R 32 is a radical selected from the group consisting of
• R 3 2 1 is a radical selected from the group consisting of
• R 322 COOR 322 1 , CONR 3 22 1 R 3222 , 4-pyrdinyl or a radical selected from the group consisting of
• R 32 is 2 H or methyl; R 322 is 2 H or methyl; or
• R 33 is H, methyl or ethyl
• R b R 4 , CH 2 OCH 3 or OH;
• B is methylene, propylene
• R 7 is H or methyl
• R 72 is H or methyl
• R a , R b and R c have the abovementioned meaning, as well as pharmacologically acceptable salt, diastereomers, enantiomers, racemates, hydrates or solvates thereof.
• R a is aryl optionally substituted with one or more radicals selected from the group consisting of R 1 , R 2 and R 3 ;
• R 1 and R 2 are independently C 1-6 alkyl, C 1-6 haloalkyl, C 1 ⁇ -alkoxy, halogen, COR 1 1, SO 2 R 1 1, R 1 1 C 1-6 alkyl, NR 1 1 1 R 1 1 2
• R 1 1 1 and R 1 1 2 together form a five- or six-membered heterocyclic ring which may optionally be substituted by a radical selected from the group consisting of methyl, ethyl, propyl;
• R 3 is a radical selected from the group consisting of
• X is bond or C 1-4 alkylene
• R 3a is a radical, identical or different, selected from the group consisting of R 3 1 , R 32 and R 33 ;
• R 3 is spiro or het, wherein Het may optionally be substituted with one or more R 3 1 1 ;
• R 3 1 1 1 H 1 C 1-4 alkyl
• R 3 1 1 2 H 1 C 1-4 alkyl
• R a is phenyl optionally substituted with one or more radicals selected from the group consisting of R 1 , R 2 and R 3 ;
• R 1 and R 2 independently of one another are C 1-6 -alkyl, C 1-6 -haloalkyl, C 1-6 -alkoxy, halogen, COR 11 , SO 2 R 11 ,
• R 11 is methyl ethyl, propyl, NR 111 R 112
• R 111 is H, methyl ethyl, propyl;
• R 112 H, methyl ethyl, propyl;
• R 111 and R 112 together form a five- or six-membered heterocyclic ring which may optionally be substituted with one
• Residue selected from the group consisting of methyl, ethyl, propyl;
• R 3 is a radical selected from the group consisting of
• R 3a is a radical, identical or different, selected from the group consisting of R 31 , R 32 and R 33 ;
• R 31 is spiro or het, where Het may be optionally substituted with one or more R 311 ;
• R 3111 H methyl ethyl, propyl
• R, 3112 H methyl ethyl, propyl
• R 71 is H, methyl, ethyl, (CH 2 ) 2 R 711 or COOButyl;
• R 72 is H, methyl or ethyl;
• R a is phenyl, optionally substituted by one or more radicals selected from the group consisting of R 1 and R 2 ;
• R 1 is methyl, ethyl, propyl, CF 3 , F, Cl, COR 1 1 or SO 2 R 1 1 ;
• R 2 is methyl, F or Cl
• R 7 is H, methyl, ethyl, (CH 2 ) 2 R 7 1 1 or COOButyl;
• R 72 is H, methyl or ethyl;
• R a is phenyl optionally substituted with R 1 ;
• R 1 is methyl, F, Cl, Br or COR 1 1 ;
• R 7 is H or methyl; :> 7 2 methyl;
• R a , R b and R c have the abovementioned meaning, as well as pharmacologically acceptable salt, diastereomers, enantiomers, racemates, hydrates or solvates thereof.
• R a is aryl optionally substituted by one or more radicals selected from the group consisting of R 1 , R 2 and R 3 , or hetaryl;
• R 1 and R 2 independently of one another are C 1-6 -alkyl, C 1-6 -haloalkyl, C 1-6 -alkoxy, halogen, COR 1 1 ;
• R 1 1 OH C 1-6 alkyl, NR 1 1 1 R 1 1 2
• R 3a is a radical, identical or different, selected from the group consisting of R 3 1 , R 32 and R 33 ;
• R 3 is spiro or het, wherein Het may optionally be substituted with one or more R 3 1 1 ;
• R 3 1 1 1 H, C 1-4 alkyl
• R 3 1 1 2 H, C 1-4 alkyl
• R a is phenyl, optionally substituted by one or more radicals selected from the group consisting of R 1 , R 2 and R 3 , pyrazolyl or pyridinyl; R 1 and R 2 independently of one another are C 1-6 -alkyl, C 1-6 -haloalkyl, C 1-6 -alkoxy, halogen, COR 11 ,
• R 11 is methyl ethyl, propyl, NR 111 R 112
• R 111 is H, methyl ethyl, propyl;
• R 112 H, methyl ethyl, propyl;
• R 111 and R 112 together form a five- or six-membered heterocyclic ring which may optionally be substituted with one
• Residue selected from the group consisting of methyl, ethyl, propyl;
• R 3 is a radical selected from the group consisting of
• R 3a is a radical, identical or different, selected from the group consisting of R 31 , R 32 and R 33 ;
• R 31 is spiro or het, where Het may be optionally substituted with one or more R 311 ;
• R 3111 H methyl ethyl, propyl
• R 3112 H methyl ethyl, propyl
• R b is R 4 or OH; H;
• R 7 H NR 7 1 R 7 2 or a radical selected from the group consisting of
• R 7 1 H methyl or (CH 2 ) 2 R 7 1 1 ;
• R 72 is H, methyl or ethyl
• R a is phenyl optionally substituted by one or more radicals selected from the group consisting of R and R; or
• R 1 is methyl, methoxy, Cl, OH or COR 11 ;
• R 11 is NH 2 , NHMe or NMe 2 ;
• R 2 is methoxy or Cl
• R b is R 4 or OH
• R 7 H NR 71 R 72 or a radical selected from the group consisting of
• R 71 is H, methyl or (CH 2 ) 2 R 711 ;
• R 72 is H, methyl or ethyl; R / ⁇ ⁇ NMe 2 ;
• R a is phenyl, optionally substituted by one or more radicals selected from the group consisting of R 1 , R 2 and R 3 ; or
• R 1 is Cl or COR 1 1 ;
• R b is R 4 or OH
• R 7 H pharmacologically acceptable salts, diastereomers, enantiomers, racemates, hydrates or solvates thereof.
• R a , R b and R c have the abovementioned meaning, as well as pharmacologically acceptable salt, diastereomers, enantiomers, racemates, hydrates or solvates thereof.
• R a is phenyl, optionally substituted by one or more radicals selected from the group consisting of R 1 and R 3 ; or
• R 1 is methyl, F, Cl or Br
• R 3 is a radical selected from the group consisting of
• R 4 is a radical selected from the group consisting of
• R 7 H pharmacologically acceptable salts, diastereomers, enantiomers, racemates, hydrates or solvates thereof.
• R a is phenyl, optionally substituted by one or more radicals selected from the group consisting of R 1 and R 3 ; or
• R 3 is a radical selected from the group consisting of
• R 33 is H; R 4
• R a is H, d-8 alkyl, C 2-6 alkenyl, C 3-8 cycloalkyl, C 3-8 cycloalkenyl, C 1-6 haloalkyl, COR 8, NR 9 R 10, NO 2, OR 8 , SR 11 , SOR 11 , SO 2 R 11 , NHCO-C 1-6 alkyl-NH 2 , spiro or a radical selected from the group consisting of C 7-11 aralkyl, CH 2 -O-aryl and het which may be optionally substituted with one or more halogen, C 1-6 alkyl, CO-C 1-4 haloalkyl, C 1-4 alkyl-NH 2 or CH 2 NHCOOR 12 ;
• R 8 is C 1-6 alkyl, C 3-6 cycloalkyl, NH 2 , hetaryl or aryl optionally substituted with one or more halo or C 1-4 alkyl;
• R 9 is H, COOR 12 , CONR 12 or C 1-6 alkyl optionally substituted with one or more COOH, N (C 1-6 alkyl) 2 or Het optionally substituted with one or more C 1-6 alkyl ; or R 9 is het optionally substituted with one or more C 1-4 alkyl;
• R 10 is H, C 1-6 -alkyl, CO-C 1-6 -alkyl or C 2 . 6- alkynyl;
• R 11 is C 1-6 alkyl optionally substituted with one or more N (C 1-4 alkyl) 2 ;
• R 12 is H, C 1-6 -alkyl
• R 4 , R 5 is H, C 1-6 -alkyl, C 1-6 -haloalkyl, C 1-6 -alkylene-OH, C 1-6 -alkenyl, dn-aralkyl, C 1-4 -alkenyl-aryl, C 1-4 -alkynyl-aryl, C 1-4 -alkyl-hetaryl, C 1-4 -alkenyl-hetaryl, C 1-4 -alkynyl-hetaryl, C 2-6 -alkynyl, optionally substituted by Si (C 1 4- alkyl) 3 , or R 4 is a radical selected from the group consisting of aryl, het, hetaryl and optionally substituted by C 1 4 -alkyl;
• R 4 and R 5 together form a five, six or seven membered ring consisting of carbon atoms and optionally a heteroatom selected from the group consisting of oxygen, nitrogen and sulfur;
• R c NHR 6 or a radical selected from the group consisting of
• B bond C 1-6 alkyl, C 2-6 alkenyl or C 2-6 alkynyl; H or a radical selected from the group consisting of C 1-4 -alkyl, C 2-4 -alkenyl, C 2-4 -alkynyl, C 3-6 -cycloalkyl, C 3-6 -cycloalkenyl, het, aryl, hetaryl with one or more radicals R 6 1 ;
• R 6 1 is halogen, CF 3 , OH, CN, OMe, SO 2 (C 1-4 alkyl);
• R 7 is H, C 1-4 alkyl, C 2-4 alkenyl, C 2-4 alkynyl, C 3-6 cycloalkyl, NR 7 1 R 72 , OR 72 , SR 72 , hetaryl, Het, optionally substituted with C 1-4 alkyl or CONH 2 ;
• R 7 is H, C 1-6 alkyl, (CH 2 ) 2 _ 4 R 7 1 1 or COOButyl;
• R 72 is H, C 1-6 -alkyl, optionally substituted with one or more OH;
• R 7 i 1 NR 7 1 1 1 R 7 1 1 2 Het or 1 -imidazolyl, 2- (N-ethylpyrollidine);
• R 7 1 1 1 is H or C 1-6 alkyl
• R 7 is 1 H 2 or C 1-6 alkyl
• R a is H, C 1-6 alkyl, C 2-6 alkenyl, C 3 _ 8 cycloalkyl, C 3 _ 8 cycloalkenyl, C 1-6 haloalkyl, COR 8, NR 9 R 10, NO 2, OR 8 , SR 11 , SOR 11 , SO 2 R 11 , NHCO-C 1-6 -alkyl-NH 2 , spiro or a radical selected from the group consisting of C 7-11 -aralkyl, CH 2 -O-aryl and Het which may optionally be substituted with one or more halo, C 1-6 alkyl, CO-C 1-4 haloalkyl, C 1-4 alkyl-NH 2 or CH 2 NHCOOR 12 ;
• R 8 is C 1-6 alkyl, C 3-6 cycloalkyl, NH 2 , hetaryl or aryl optionally substituted with one or more halo or C 1-4 alkyl;
• R 9 is H, COOR 12 or C 1-4 alkyl optionally substituted with one or more COOH, N (C 1-4 alkyl) 2 or Het optionally substituted with one or more C 1-4 alkyl; or R 9 is het optionally substituted with one or more C 1-4 alkyl;
• R 10 is H, C 1 6 -alkyl, CO-C 1-4 -alkyl or C 2 6 alkynyl;
• R 11 is C 1-6 alkyl optionally substituted with one or more N (C 1-4 alkyl) 2 ;
• R 12 is C 1-6 alkyl
• R 4 is H, C 1-6 -alkyl, C 1-6 -haloalkyl, C 1-6 -alkylene-OH, C 2-6 -alkenyl, dn-aralkyl, C 2-4 -alkenyl-aryl, C 2- 4 -alkynyl-aryl, C 1-4 alkyl hetaryl, hetaryl-C 2-4 alkenyl, C 2-4 alkynyl-hetaryl, C 2-6 alkynyl, optionally substituted by Si (C 1 -C 4 alkyl ) 3 , or R 4 is a radical selected from the group consisting of aryl, Het,
• R 5 is H or C 1-6 alkyl
• R 4 and R 5 together form a five, six or seven membered ring consisting of carbon atoms and optionally a heteroatom selected from the group consisting of oxygen, nitrogen and sulfur;
• R c NHR 6 or a radical selected from the group consisting of
• R 6 is H or a radical selected from the group consisting of C 1-4 -alkyl, C 2-4 -alkenyl, C 2-4 -alkynyl, C 3-6 -cycloalkyl, C 3-6 -cycloalkenyl, het, aryl, hetaryl optionally substituted with one or more R 6 1 ;
• R 6 1 is halogen, CF 3 , OH, CN, OMe, SO 2 (C 1-4 alkyl);
• R 7 is H, C 1-4 alkyl, C 2-4 alkenyl, C 2-4 alkynyl, C 3-6 cycloalkyl, NR 7 1 R 72 , OR 72 , SR 72 , hetaryl, Het, optionally substituted with C 1-4 alkyl or CONH 2 ;
• R 7 is H, C 1-4 alkyl, (CH 2 ) 2 _ 4 R 7 1 1 or COOButyl;
• R 72 is H, C 1-6 -alkyl, optionally substituted with one or more OH;
• R 7 1 1 NR 7 1 1 1 R 7 1 1 2 Het or 1-imidazolyl, 2- (N-ethylpyrollidine);
• R 7 1 1 1 is H or C 1-6 alkyl; R 7 is 1 H 2 or C 1-6 alkyl;
• R a is H, C 1-6 alkyl, C 2-6 alkenyl, C 3 _ 6 cycloalkyl, C 3 _ 6 cycloalkenyl, C 1-6 haloalkyl, COR 8, NR 9 R 10, NO 2, OR 8 , SR 11 , SOR 11 , SO 2 R 11 , NHCO-C 1-6 -alkyl-NH 2 , spiro or a radical selected from the group consisting of C 7-11 -aralkyl, CH 2 -O-aryl and Het which may optionally be substituted with one or more halo, C 1-6 alkyl, CO-C 1-4 haloalkyl, C 1-4 alkyl-NH 2 or CH 2 NHCOOR 12 ;
• R 8 is C 1-6 alkyl, C 3-6 cycloalkyl, NH 2 , hetaryl or aryl optionally substituted with one or more halo or C 1-4 alkyl;
• R 9 is H, COOR 12 or C 1-4 alkyl optionally substituted with one or more COOH, N (C 1-4 alkyl) 2 or Het optionally substituted with one or more C 1-4 alkyl; or R 9 is het optionally substituted with one or more C 1-4 alkyl;
• R 10 is H, C 1-6 -alkyl, CO-C 1-4 -alkyl or C 2-6 -alkynyl;
• R 11 is C 1-6 alkyl optionally substituted with one or more N (C 1-4 alkyl) 2 ;
• R 12 is C 1-6 alkyl
• R b R 4 , OR 4 , -CH 2 OR 4 , COR 4 , COOR 4 , CONR 4 R 5 , NH 2 , NR 5 COOR 4 , NR 5 CONR 4 R 5 or NR 5 SOR 4 ;
• R 4 is H, C 1-8 -alkyl, C 1-6 -haloalkyl, C 1-6 -alkylene-OH, C 2-6 -alkenyl, C 7 _n-aralkyl, C 1-4 -alkyl-hetaryl, C 2 -6 alkynyl, optionally substituted with Si 3, or R 4 represents a radical selected from the group consisting of aryl, Het, hetaryl and optionally substituted with C 1-4 alkyl (C 1 4 alkyl.);
• R 5 is H or C 1-6 alkyl
• R 4 and R 5 together form a five, six or seven membered ring consisting of carbon atoms and optionally a heteroatom selected from the group consisting of oxygen, nitrogen and sulfur;
• R c NHR 6 or a radical selected from the group consisting of
• R 6 is H or a radical selected from the group consisting of C 1-4 -alkyl, C 3-6 -cycloalkyl, het, aryl, hetaryl, optionally substituted by one or more radicals R 6 1 ;
• R 6 1 is halogen, CF 3 , OH, CN, OMe, SO 2 (C 1-4 alkyl);
• R 7 is H, C 1-4 alkyl, C 3-6 cycloalkyl, NR 7 1 R 72 , OR 72 , SR 72 , hetaryl, Het optionally substituted with C 1-4 alkyl or CONH 2 ;
• R 7 is H, C 1-4 alkyl, (CH 2 ) 2 _ 4 R 7 1 1 or COOButyl;
• R 72 is H, C 1-6 -alkyl, optionally substituted with one or more OH;
• R 7 1 1 NR 7 1 1 1 R 7 1 1 2 Het or 1-imidazolyl, 2- (N-ethylpyrollidine);
• R 7 1 1 1 is H or C 1-6 alkyl; R 7 is 1 H 2 or C 1-6 alkyl;
• R a is H, C 1-6 -AIkIyI, C 2-6 alkenyl, C 3 _ 6 cycloalkyl, CF 3, COR 8, NR 9 R 10, NO 2, S (O) n R 11, or a radical selected from the group consisting of
• R 8 is C 1-4 alkyl, C 3-6 cycloalkyl, NH 2 , furanyl or phenyl optionally substituted with one or more chloro;
• R 9 is H, COOR 12 or piperidino, optionally substituted with one or more CH 3, or a radical selected from the group consisting of C 1 4 alkyl, which may be optionally substituted with one or more COOH, NMe 2 or 4-methylpiperazine ;
• R 10 is H, C 1-4 alkyl, C 2-4 alkynyl or COCH 3 ;
• R 11 is C 1-4 -alkyl, optionally substituted by one or more NMe 2 , R 12 is C 1-4 alkyl;
• R b R 4 , CH 2 OR 4 , COR 4 , COOR 4 , CONR 4 R 5 , NH 2 , NHCOOR 4 , NHCONR 4 R 5 or OH;
• R 4 is H, C 1-4 -alkyl, C 1-4 -alkylene-OH, C 2-4 -alkynyl, C 1-6 -haloalkyl, aryl, het, hetaryl,
• R 5 is H or C 1-4 alkyl
• NHR 6 or a residue selected from the group consisting of
• R 6 is H, C 1-4 alkyl, C 3-6 cycloalkyl, C 7-11 aralkyl, aryl optionally substituted with SO 2 CH 3 ;
• R 7 is H, NR 7 1 R 72 , OR 72 , SR 72 , hetaryl, Het, optionally substituted by C 1-4 -alkyl or CONH 2 , or a radical selected from the group consisting of
• R 7 is H, C 1-4 alkyl, (CH 2 ) 2 R 7 1 1 or COOButyl;
• R 72 is H, C 1-4 alkyl;
• R 7 1 1 NR 7 1 1 1 R 7 1 1 2 Het or 1 -imidazolyl, 2- (N-ethylpyrollidine);
• R 7 1 1 1 is H or C 1-6 alkyl; R 7 is 1 H 2 or C 1-6 alkyl;
• R a is H, C 1-6 -alkyl, C 2-6 -alkenyl, C 3-6 -cycloalkyl, C 3-6 -cycloalkenyl, CF 3 , COR 8 , NR 9 R 10 ,
• R 8 is C 1-4 alkyl, C 3-6 cycloalkyl, NH 2 , hetaryl, aryl, optionally substituted with one or more chlorine;
• R 9 is H, COOR 12 or Het, optionally substituted with one or more C 1-4 alkyl, or a radical selected from the group consisting of C 1-4 alkyl, which may be optionally substituted with one or more COOH,
• R 1 0 H, C 1-4 alkyl, C 2-4 alkynyl or COCH 3;
• R 11 is C 1-4 -alkyl, optionally substituted with one or more N (C 1-4 -alkyl) 2 ,
• R 12 is C 1-4 alkyl
• n 0 or 2;
• R b is H, OH or COOEt
• R c is NH 2 or NHCOR 13 ;
• R 13 is C 1-4 -alkyl, or NR 13 1 R 132 ,
• R 13 is H or C 1-4 alkyl
• R 132 is H or C 1-4 alkyl
• R a is H, C 1-6 -AIkIyI 1 C 2-6 alkenyl, C 3-6 cycloalkyl, CF 3, COR 8, NR 9 R 10, NO 2, S (O) n R 11, or a radical selected from the group consisting of
• R 8 is C 1-4 alkyl, C 3-6 cycloalkyl, NH 2 , furanyl or phenyl optionally substituted with one or more chloro;
• R 9 is H, COOR 12 or piperidino, optionally substituted by one or more CH 3 , or a radical selected from the group consisting of C 1-4 -alkyl, which may optionally be substituted by one or more COOH, NMe 2 or 4- methylpiperazine;
• R 10 is H, C 1-4 alkyl, C 2-4 alkynyl or COCH 3 ;
• R 11 is C 1-4 -alkyl, optionally substituted by one or more NMe 2 ,
• R 12 is C 1-4 alkyl
• R b is H, OH or COOEt;
• R c is NH 2 or NHCOR 13 ;
• R 13 is C 1-4 -alkyl, or NR 13 1 R 13 2 ,
• R 13 is H or C 1-4 alkyl;
• R 132 is H or C 1-4 alkyl;
• R a is H, methyl, ethyl, propyl, butyl, 3-methyl-butyl, propenyl, cyclopropyl, cyclohexyl,
• R 8 is methyl, propyl, cyclopropyl, NH 2 , furanyl or phenyl optionally substituted with one or more chloro;
• R 9 is H, COOR 12 or piperidino, optionally substituted with one or more CH 3, or a radical selected from the group consisting of methyl, ethyl and propyl, which may be optionally substituted with one or more COOH, NMe 2 or 4-methylpiperazine ;
• R 10 is H, methyl, COCH 3 , C ⁇ CH or CH 2 C ⁇ CH;
• R 11 is ethyl or propyl, optionally substituted by one or more NMe 2 ,
• R b is H, OH or COOEt
• R c is NH 2 or NHCOR 13 ;
• R 13 is methyl or NR 13 1 R 132 ,
• R a is Propyl, COR 8 , NR 9 R 10 , S (O) n R 11 and
• R 9 is methyl
• R 10 is methyl
• R b is H or OH
• R c is NH 2 or NHCOCH 3 ;
• C 1-6 -alkyl (including those which are part of other groups) is understood to mean branched and unbranched alkyl groups having 1 to 6 carbon atoms and branched and unbranched alkyl groups having 1 to 10 by the term "C 1-4 -alkyl” 4 carbon atoms understood. Preference is given to alkyl groups having 1 to 4 carbon atoms. Examples include: methyl, ethyl, n-propyl, / so-propyl, n-butyl, / so-butyl, sec-butyl, terf-butyl, n-pentyl, / so-pentyl, neo-pentyl or hexyl.
• the abbreviations Me, Et, n-Pr, / -Pr, n-Bu, / -Bu, t-Bu, etc. are also used for the abovementioned groups.
• the definitions of propyl, butyl, pentyl and hexyl include all conceivable isomeric forms of the respective radicals.
• propyl includes n-propyl and / so-propyl
• butyl includes / so-butyl, sec-butyl and tert-butyl, etc.
• C 1-6 -alkylene (including those which are part of other radicals) are to be understood as meaning branched and unbranched alkylene groups having 1 to 6 carbon atoms and branched and unbranched alkylene groups having 1 to 10 by the term “C 1-4 -alkylene” 4 carbon atoms understood. Preference is given to alkylene groups having 1 to 4
• Carbon atoms include: methylene, ethylene, propylene, 1-methylethylene, butylene, 1-methylpropylene, 1, 1-dimethylethylene, 1, 2-dimethylethylene, Pentylene, 1, 1-dimethylpropylene, 2,2, -dimethylpropylene, 1, 2-dimethylpropylene, 1, 3-dimethylpropylene or hexylene.
• propylene, butylene, pentylene and hexylene include all conceivable isomeric forms of the respective radicals of the same carbon number.
• propyl also includes 1-methylethylene and butylene includes 1-methylpropylene, 1, 1-dimethylethylene, 1, 2-dimethylethylene.
• C 2-6 alkenyl (including those which are part of other radicals) are branched and unbranched alkenyl groups having 2 to 6 carbon atoms and the term “C 2-4 alkenyl” branched and unbranched alkenyl groups having 2 to 4 Carbon atoms understood, as far as they have at least one double bond.
• alkenyl groups having 2 to 4 carbon atoms examples include: ethenyl or vinyl, propenyl, butenyl, pentenyl, or hexenyl. Unless otherwise described, the definitions propenyl, butenyl, pentenyl and hexenyl include all conceivable isomeric forms of the respective radicals.
• propenyl includes 1-propenyl and 2-propenyl
• butenyl includes 1-, 2- and 3-butenyl, 1-methyl-1-propenyl, 1-methyl-2-propenyl, etc.
• C 2-6 alkenylene (including those which are part of other radicals) is understood as meaning branched and unbranched alkenylene groups having 2 to 6 carbon atoms and branched and unbranched alkylene groups having 2 to 6 under the term "C 2-4 alkenylene” 4 carbon atoms understood. Alkenylene groups having 2 to 4 carbon atoms are preferred.
• Examples include: ethenylene, propenylene, 1-methylethenylene, butenylene, 1-methylpropenylene, 1, 1 - dimethylethenylene, 1, 2-dimethylethenylene, pentenylene, 1, 1-dimethylpropenylene, 2,2, - dimethylpropenylene, 1, 2- Dimethylpropenylene, 1, 3-dimethylpropenylene or hexenylene.
• propenylene, butenylene, pentenylene and hexenylene include all conceivable isomeric forms of the respective radicals of equal carbon number.
• propenyl also includes 1-methylethenylene and butenylene includes 1-methylpropenylene, 1, 1-dimethylethenylene, 1, 2-dimethylethenylene.
• C 2-6 -alkynyl (including those which are part of other radicals) are branched and unbranched alkynyl groups having 2 to 6 carbon atoms and under the term “C 2-4 alkynyl” means branched and unbranched alkynyl groups having 2 to 4 carbon atoms, provided they have at least one triple bond. Preferred are alkynyl groups having 2 to 4 carbon atoms. Examples include: ethynyl, propynyl, butynyl, pentynyl, or hexynyl.
• propynyl includes 1-propynyl and 2-propynyl
• butinyl includes 1-, 2- and 3-butynyl, 1-methyl-1-propynyl, 1-methyl-2-propynyl, etc.
• C 2-6 -alkynylene (even if they are part of other groups) are branched and unbranched alkynylene groups having 2 to 6 carbon atoms and the term “C 2-4 -alkynylene” branched and unbranched alkylene groups having 2 to 4 carbon atoms understood. Alkynylene groups having 2 to 4 carbon atoms are preferred. Examples include: ethynylene, propynylene, 1-methylethynylene, butynylene, 1-methylpropynylene, 1, 1 -
• the definitions propynylene, butynylene, pentynylene and hexynylene include all conceivable isomeric forms of the respective radicals of the same carbon number.
• propynyl also includes 1-methylethynylene and butynylene includes 1-methylpropynylene, 1, 1-dimethylethynylene, 1, 2-dimethylethynylene.
• C 1 ⁇ -alkoxy (even if they are part of other radicals) are branched and unbranched alkoxy groups having 1 to 6 carbon atoms and the term "C 1-4 alkoxy” branched and unbranched alkoxy groups having 1 to 4 Understood carbon atoms. Preferred are alkoxy groups having 1 to 4 carbon atoms. Examples include: methoxy, ethoxy, propoxy, butoxy or pentoxy. If appropriate, the abbreviations OMe, OEt, OPr, etc. are also used for the abovementioned groups. Unless otherwise stated, the definitions of propoxy, butoxy and pentoxy include all conceivable isomeric forms of the respective radicals.
• propoxy includes n-propoxy and / so-propoxy, butoxy includes / so-butoxy, sec-butoxy and terf-butoxy, etc.
• C 3-8 -cycloalkyl (including those which are part of other groups) cyclic alkyl groups having 3 to 8 carbon atoms are understood, cyclic, the term “C 3-6 cycloalkyl” are alkyl groups having 3 to 8 carbon atoms and the term "C 5, 6 -cycloalkyl” means cyclic alkyl groups having 5 to 6 carbon atoms. Examples include: cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl or cyclooctyl.
• C 3-6 -cycloalkenyl means cyclic alkyl groups having 5 or 6 carbon atoms which contain one or two double bonds. Examples include: cyclopentenyl, cyclopentadienyl, cyclohexenyl or cyclohexadienyl.
• C 1-6 haloalkyl (including those which are part of other radicals) are understood as meaning branched and unbranched alkyl groups having 1 to 6 carbon atoms in which one or more hydrogen atoms are selected from the group consisting of fluorine, chlorine or bromine by a halogen atom , preferably fluorine and chlorine, particularly preferably fluorine are exchanged.
• C 1-4 -haloalkyl means correspondingly branched and unbranched alkyl groups having 1 to 4 carbon atoms, in which one or more hydrogen atoms have been exchanged analogously as described above.
• C 1-4 haloalkyl For example: CH 2 F, CHF 2 , CF 3 ,
• C 7-11 -aralkyl (including those which are part of other groups) means branched and unbranched alkyl groups having 1 to 4 carbon atoms which are substituted by an aromatic ring system having 6 carbon atoms.
• aromatics may be substituted with one or more radicals selected from the group consisting of methyl, ethyl, / so-propyl, tert-butyl, hydroxy, fluorine, chlorine, bromine and iodine.
• aryl (even if they are part of other radicals) are understood as meaning aromatic ring systems having 6 or 10 carbon atoms. For example: phenyl or naphthyl, more preferably aryl is phenyl.
• heterocyclic rings (“Het”) is understood as meaning five-, six- or seven-membered, saturated or unsaturated heterocyclic rings or 5-10-membered, bicyclic hetero rings, the one, two or three heteroatoms selected from the group consisting of oxygen, sulfur and nitrogen In this case, the ring may be linked to the molecule via a carbon atom or, if present, via a nitrogen atom.
• heterocyclic rings As examples of five-, six- or seven-membered, saturated or unsaturated heterocyclic rings, mention is made:
• a heterocyclic ring may be provided with a keto group. As an example for this are called.
• pyrrolizine indole, indolizine, isoindole, indazole, purine, quinoline, isoquinoline, benzimidazole, benzofuran, benzopyran, benzothiazole, benzothiazole, benzoisothiazole, pyridopyrimidine, pteridine, pyrimidopyrimidine,
• heterocyclic rings include, the term heterocyclic aromatic defines five- or six-membered heterocyclic aromatic or 5-10 membered, bicyclic Hetarylringe the one, two or three heteroatoms selected from the group can contain oxygen, sulfur and nitrogen, and contain as many conjugated double bonds that an aromatic system is formed.
• the ring may be linked to the molecule via a carbon atom or, if present, via a nitrogen atom.
• five- or six-membered heterocyclic aromatic compounds there are mentioned:
• Examples of 5-10 membered bicyclic hetaryl rings include pyrrolizine, indole, indolizine, isoindole, indazole, purine, quinoline, isoquinoline, benzimidazole, benzofuran, benzopyran, benzothiazole, benzothiazole, benzoisothiazole, pyridopyrimidine, pteridine, pyrimidopyrimidine.
• heterocyclic spiro rings is understood to mean 5-10 membered spirocyclic rings which may optionally contain one, two or three heteroatoms selected from the group consisting of oxygen, sulfur and nitrogen, in which case the ring may have a carbon atom or, if present be linked to the molecule via a nitrogen atom. Unless otherwise stated, a spirocyclic ring may be provided with a keto group. As examples are mentioned:
• the term "optionally substituted” is understood to mean the abovementioned group which is optionally substituted by a lower-molecular radical.
• Low-molecular radicals are understood to be chemically meaningful groups consisting of 1-200 atoms. Preferably, such groups have no negative effect on the pharmacological activity of the compounds.
• the groups may include:

Landscapes

• Health & Medical Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Life Sciences & Earth Sciences (AREA)
• Veterinary Medicine (AREA)
• Public Health (AREA)
• General Health & Medical Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• Medicinal Chemistry (AREA)
• Pharmacology & Pharmacy (AREA)
• General Chemical & Material Sciences (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Engineering & Computer Science (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Pulmonology (AREA)
• Dermatology (AREA)
• Oncology (AREA)
• Communicable Diseases (AREA)
• Immunology (AREA)
• Rheumatology (AREA)
• Pain & Pain Management (AREA)
• Ophthalmology & Optometry (AREA)
• Virology (AREA)
• Orthopedic Medicine & Surgery (AREA)
• Physical Education & Sports Medicine (AREA)
• Urology & Nephrology (AREA)
• Gastroenterology & Hepatology (AREA)
• Epidemiology (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Priority Applications (8)

Applications Claiming Priority (4)

Publications (1)

Family

ID=35583390

Family Applications (1)

Country Status (14)

Cited By (29)

Families Citing this family (17)

Citations (4)

Family Cites Families (23)

• 2005
  • 2005-10-05 AU AU2005293607A patent/AU2005293607A1/en not_active Abandoned
  • 2005-10-05 RU RU2007116858/04A patent/RU2403258C2/ru not_active IP Right Cessation
  • 2005-10-05 RU RU2007116861/04A patent/RU2007116861A/ru not_active Application Discontinuation
  • 2005-10-05 EP EP05805652A patent/EP1802636B1/de not_active Expired - Lifetime
  • 2005-10-05 EP EP11158787A patent/EP2343303A1/de not_active Withdrawn
  • 2005-10-05 KR KR1020077010387A patent/KR20070064660A/ko not_active Withdrawn
  • 2005-10-05 WO PCT/EP2005/055015 patent/WO2006040279A1/de not_active Ceased
  • 2005-10-05 US US11/243,796 patent/US7691888B2/en not_active Expired - Lifetime
  • 2005-10-05 BR BRPI0516557-1A patent/BRPI0516557A/pt not_active IP Right Cessation
  • 2005-10-05 MX MX2007004051A patent/MX2007004051A/es not_active Application Discontinuation
  • 2005-10-05 CN CNA2005800344060A patent/CN101048418A/zh active Pending
  • 2005-10-05 CA CA2579279A patent/CA2579279C/en not_active Expired - Lifetime
  • 2005-10-05 JP JP2007535159A patent/JP5122287B2/ja not_active Expired - Lifetime
  • 2005-10-05 US US11/244,299 patent/US20060106013A1/en not_active Abandoned
  • 2005-10-06 TW TW094134899A patent/TW200628475A/zh unknown
  • 2005-10-07 AR ARP050104225A patent/AR055273A1/es unknown
• 2007
  • 2007-04-10 IL IL182398A patent/IL182398A0/en unknown
• 2009
  • 2009-02-05 US US12/366,248 patent/US8232286B2/en active Active
• 2010
  • 2010-01-11 US US12/685,213 patent/US8207349B2/en not_active Expired - Lifetime

Patent Citations (4)

Non-Patent Citations (3)

Also Published As

Similar Documents

Legal Events